Frequencies for first 10,000 rows of dose_vbm variable in drug2016q1 dataset : Verbatim text for dose, frequency, and | route, exactly as entered on report | Freq. Percent Cum. ----------------------------------------+----------------------------------- | 4,130 41.30 41.30 '3000 VI' | 1 0.01 41.31 (2DOSES)TABLET | 1 0.01 41.32 (STOP DATE: 25 SEP 2008) | 1 0.01 41.33 . | 1 0.01 41.34 . TOOK 1 PACKET,FREQUENCY UNK | 1 0.01 41.35 .03 G, UNK | 1 0.01 41.36 .05 MG, QD | 1 0.01 41.37 .1 %, BID | 1 0.01 41.38 .1 MG/KG, UNK | 1 0.01 41.39 .125 MG, QD | 1 0.01 41.40 .15 EVERY OTHER DAY THEN .175 EVERY O.. | 1 0.01 41.41 .15 MG, QD | 1 0.01 41.42 .15 MG, UNK | 1 0.01 41.43 .25 MG, BID | 1 0.01 41.44 .3 G, UNK | 1 0.01 41.45 .4 MG, ONCE DAILY (QD) | 1 0.01 41.46 .4 MG, QD | 1 0.01 41.47 .4 MG, UNK | 1 0.01 41.48 .5 %, QID | 1 0.01 41.49 .5 MG, BID | 1 0.01 41.50 .5 MG, QD | 26 0.26 41.76 .5 MG, QID | 2 0.02 41.78 .5 MG, UNK | 2 0.02 41.80 .5 ML | 3 0.03 41.83 .5 ML, BID | 1 0.01 41.84 .5 ML, QD | 1 0.01 41.85 .5 ML, QID | 1 0.01 41.86 .75 MG, UNK | 1 0.01 41.87 .8 MG, QD | 1 0.01 41.88 0.02% CREAM.APPLY TO AFFECTED AREA | 1 0.01 41.89 0.02% SOLUTION 1 VILE INHALATION NEEDED | 1 0.01 41.90 0.03 MG, DAILY | 1 0.01 41.91 0.05 MG, UNK | 1 0.01 41.92 0.05 MG/INH SPRAY, 2 SPRAY IN EACH NO.. | 1 0.01 41.93 0.1 MG, QD | 1 0.01 41.94 0.1 MUG/KG, 3 TIMES/WK | 1 0.01 41.95 0.125 MG | 1 0.01 41.96 0.125 MG, ONCE DAILY | 1 0.01 41.97 0.125 MG, QD | 1 0.01 41.98 0.125 MG, UNK | 1 0.01 41.99 0.15 ?G, UNKNOWN | 2 0.02 42.01 0.2 MG, 1X/DAY | 1 0.01 42.02 0.2 MG, 6X/WEEK | 2 0.02 42.04 0.2 MG, QD | 2 0.02 42.06 0.2 MG, UNK | 2 0.02 42.08 0.2%DROPS,B/W 7-8MG/DIE | 1 0.01 42.09 0.25 ?G, UNKNOWN | 2 0.02 42.11 0.25 MG, 2X/DAY | 1 0.01 42.12 0.25 MG, AS NEEDED | 1 0.01 42.13 0.25 MG, AS NEEDED(1 TABLET ORALLY TW.. | 1 0.01 42.14 0.25 MG, BID | 1 0.01 42.15 0.25 MG, EACH EVENING | 1 0.01 42.16 0.25 MG, ONCE DAILY | 1 0.01 42.17 0.25 MG, QD | 2 0.02 42.19 0.25 MG, QD (STOP DATE: 25 SEP 2008) | 2 0.02 42.21 0.25 MG, TID | 1 0.01 42.22 0.25 MG, UNK | 3 0.03 42.25 0.25 MUG, QD | 1 0.01 42.26 0.3 MG PER DAY | 1 0.01 42.27 0.3 MG, EVERY 48 HOURS | 1 0.01 42.28 0.3 MG, EVERY 5 MINUTES | 1 0.01 42.29 0.3 MG, QD | 1 0.01 42.30 0.33 G, TID | 1 0.01 42.31 0.375 MG, QD | 1 0.01 42.32 0.4 MG, BID | 1 0.01 42.33 0.4 MG, PRN | 1 0.01 42.34 0.4 MG, QD | 2 0.02 42.36 0.4 MG, TID | 2 0.02 42.38 0.4 ML, UNK | 1 0.01 42.39 0.4 UG/KG/MIN (2 ML/HOUR) | 1 0.01 42.40 0.5 %, UNK | 1 0.01 42.41 0.5 ?G, UNKNOWN | 1 0.01 42.42 0.5 DF, DAILY | 1 0.01 42.43 0.5 DF, ONCE DAILY | 1 0.01 42.44 0.5 G, QD | 1 0.01 42.45 0.5 G, TID | 1 0.01 42.46 0.5 MG | 1 0.01 42.47 0.5 MG BID | 1 0.01 42.48 0.5 MG, 1X/DAY | 2 0.02 42.50 0.5 MG, 2X/DAY | 1 0.01 42.51 0.5 MG, 3X/DAY | 2 0.02 42.53 0.5 MG, CONTINUOUS | 1 0.01 42.54 0.5 MG, EACH EVENING | 1 0.01 42.55 0.5 MG, ONCE DAILY | 2 0.02 42.57 0.5 MG, PRN | 3 0.03 42.60 0.5 MG, Q 6 H AS NEEDED | 1 0.01 42.61 0.5 MG, QD | 23 0.23 42.84 0.5 MG, QID | 1 0.01 42.85 0.5 MG, UNK | 9 0.09 42.94 0.5 MG/2 ML 1 INHALATION | 1 0.01 42.95 0.5 MG/KG, 1X/WEEK | 1 0.01 42.96 0.5 UG, QD | 1 0.01 42.97 0.5 UG/KG/MIN (2.4 ML/HOUR) | 1 0.01 42.98 0.5/3MG | 1 0.01 42.99 0.6 EVERY OTHER DAY | 1 0.01 43.00 0.6 G, 1X/DAY | 1 0.01 43.01 0.6 G/DAY | 1 0.01 43.02 0.6 MG, 1X/DAY | 2 0.02 43.04 0.6 MG, 5X/WEEK THEN 3X/WEEK | 1 0.01 43.05 0.6 MG, AS NEEDED | 1 0.01 43.06 0.6 MG, Q4-6H (PRN) | 1 0.01 43.07 0.6 MG, QD | 1 0.01 43.08 0.6 MG, TWICE DAILY | 1 0.01 43.09 0.67 G, 3X/DAY | 1 0.01 43.10 0.72 MG, UNK | 1 0.01 43.11 0.75 G/ DAY | 1 0.01 43.12 0.75 MG, BID | 1 0.01 43.13 0.75 MG, QD | 1 0.01 43.14 0.75 UNK, QD | 1 0.01 43.15 0.8MG/2ML | 1 0.01 43.16 0.9 MG PER DAY | 1 0.01 43.17 1 % CREAM, 1 APPLICATION TO AFFECTED .. | 1 0.01 43.18 1 - 12 MG TABLET DAILY | 1 0.01 43.19 1 - 16 MG TABLET AND 1 - 8 MG TABLET .. | 1 0.01 43.20 1 - 16 MG TABLET DAILY | 1 0.01 43.21 1 A/DAY | 1 0.01 43.22 1 ANZ | 2 0.02 43.24 1 APPLICATION TO AFFECTED AREA EXTERN.. | 1 0.01 43.25 1 APPLICATION, 1X/MONTH | 1 0.01 43.26 1 CAP, QD | 2 0.02 43.28 1 CAPSULE AS NEEDED | 1 0.01 43.29 1 DF (800 X 10^4 UNITS),QOD | 1 0.01 43.30 1 DF (DAILY DOSE), QD, ORAL | 1 0.01 43.31 1 DF BID AS NEEDED | 1 0.01 43.32 1 DF, (VALSARTAN 160 MG) UNK | 1 0.01 43.33 1 DF, 1X/DAY | 3 0.03 43.36 1 DF, 1X/DAY (28, ONE TABLET DAILY) | 1 0.01 43.37 1 DF, 1X/WEEK | 1 0.01 43.38 1 DF, 2X/DAY | 2 0.02 43.40 1 DF, 3X/DAY | 2 0.02 43.42 1 DF, BID | 10 0.10 43.52 1 DF, BID (QUANTITY 60 AND REFILL 5) | 1 0.01 43.53 1 DF, INTERMITTENT | 3 0.03 43.56 1 DF, MONTHLY | 1 0.01 43.57 1 DF, PRN | 5 0.05 43.62 1 DF, Q12H | 2 0.02 43.64 1 DF, Q12MO (1 BAG PER YEAR) | 1 0.01 43.65 1 DF, Q4H (QUANTITY 100 AND REFILL 2) | 1 0.01 43.66 1 DF, QCYCLE | 1 0.01 43.67 1 DF, QD | 52 0.52 44.19 1 DF, QD (HYDROCHLOROTHIAZIDE 25 MG A.. | 1 0.01 44.20 1 DF, QD (QUANTITY 1 AND REFIL 5) | 1 0.01 44.21 1 DF, QD (QUANTITY 30 AND REFILL 5) | 2 0.02 44.23 1 DF, QD (QUANTITY 34) | 1 0.01 44.24 1 DF, QID | 1 0.01 44.25 1 DF, QID (QUANTITY 120 AND REFILLS 1) | 1 0.01 44.26 1 DF, QMO | 1 0.01 44.27 1 DF, QOD | 1 0.01 44.28 1 DF, QW3 | 1 0.01 44.29 1 DF, QWK | 1 0.01 44.30 1 DF, SINGLE | 1 0.01 44.31 1 DF, TID | 2 0.02 44.33 1 DF, UNK | 28 0.28 44.61 1 DF, UNKNOWN | 3 0.03 44.64 1 DF/DAY | 2 0.02 44.66 1 DF: 0.5 UNITS NOS | 1 0.01 44.67 1 DF: 10 1C/DIA | 1 0.01 44.68 1 DF: 25 MG AND 100 MG TABLETS | 1 0.01 44.69 1 DF:1 INJ | 1 0.01 44.70 1 DF:100 UNITS NOS | 1 0.01 44.71 1 DF:200 MG 2 TAB NIGHT | 1 0.01 44.72 1 DF= 1 MIU. FORM: POWDER AND SOLVENT.. | 2 0.02 44.74 1 DF= 1.5 UNITNOS. FORM: PROCORALAN 5 | 1 0.01 44.75 1 DF= 15 CAPS | 2 0.02 44.77 1 DF= 2 TABS | 2 0.02 44.79 1 DF= 4 TABS. FORM: 20 | 1 0.01 44.80 1 DOSE | 3 0.03 44.83 1 FOR FIRST 5 DAYS MONTH | 1 0.01 44.84 1 G | 1 0.01 44.85 1 G DAY | 1 0.01 44.86 1 G, 1X/DAY | 1 0.01 44.87 1 G, 3X/DAY | 2 0.02 44.89 1 G, BID | 1 0.01 44.90 1 G, INTERMITTENT | 1 0.01 44.91 1 G, QD | 6 0.06 44.97 1 G, QID | 1 0.01 44.98 1 G, TID | 5 0.05 45.03 1 G, UNK | 7 0.07 45.10 1 G, UNK A.C | 1 0.01 45.11 1 GM EVERY 8HRS | 1 0.01 45.12 1 GRAM CAPSULE | 1 0.01 45.13 1 GTT, 1X/DAY (1 DROP IN BOTH EYES AT.. | 1 0.01 45.14 1 GTT, 1X/DAY, (ONE TIME EVERY EVENING) | 1 0.01 45.15 1 GTT, 3X/DAY (1% DROP, ONE DROP IN B.. | 1 0.01 45.16 1 IN MORNING ,2 TABLET IN EVENING | 1 0.01 45.17 1 IN MRN AND 1 IN NOON | 1 0.01 45.18 1 MG | 3 0.03 45.21 1 MG TABLET 1-2 TABLETS EVERY 8 HOURS.. | 1 0.01 45.22 1 MG, 1X/DAY | 3 0.03 45.25 1 MG, 2X/DAY | 2 0.02 45.27 1 MG, 3X/DAY | 3 0.03 45.30 1 MG, 4X/DAY | 2 0.02 45.32 1 MG, BID | 1 0.01 45.33 1 MG, DAILY | 2 0.02 45.35 1 MG, ONCE DAILY (QD) | 1 0.01 45.36 1 MG, QD | 28 0.28 45.64 1 MG, QID | 1 0.01 45.65 1 MG, QMO | 1 0.01 45.66 1 MG, QOD | 1 0.01 45.67 1 MG, TABLET PER DAY | 1 0.01 45.68 1 MG, UNK | 14 0.14 45.82 1 MG/KG ONE HOUR BEFORE ELAPRASE INFU.. | 1 0.01 45.83 1 MG/M2, UNK | 3 0.03 45.86 1 MG/ML | 1 0.01 45.87 1 ML, TOTAL | 1 0.01 45.88 1 ML, UNK | 1 0.01 45.89 1 MUG/KG, QWK | 1 0.01 45.90 1 PILL (20 MG/50 MG) | 1 0.01 45.91 1 PUFF(S), BID | 2 0.02 45.93 1 PUFF(S), QD, 110 MCG | 1 0.01 45.94 1 PUFF(S), UNK | 1 0.01 45.95 1 PUFF(S), VA | 1 0.01 45.96 1 SPRAY, AS NEEDED | 1 0.01 45.97 1 TAB, Q4H, PRN | 1 0.01 45.98 1 TAB, QD | 2 0.02 46.00 1 TAB, TID, PRN | 1 0.01 46.01 1 TABLET EVERY 12 HRS AS NEEDED | 1 0.01 46.02 1 TABLET OF 50 MG, CYCLE 4 PER 1 | 1 0.01 46.03 1 TABLET, QM | 1 0.01 46.04 1 TABS | 1 0.01 46.05 1 U, UNK | 1 0.01 46.06 1 UG, UNK | 1 0.01 46.07 1 UKN (DROP), QD | 1 0.01 46.08 1 UNK, BID | 1 0.01 46.09 1 UNK, PRN | 1 0.01 46.10 1 UNK, QD | 1 0.01 46.11 1 UNK, UNK | 3 0.03 46.14 1 UNKNOWN, UNK | 1 0.01 46.15 1 X MONTH | 1 0.01 46.16 1,000UNITS DAILY | 1 0.01 46.17 1,5MG/ML | 1 0.01 46.18 1-10DAYS | 1 0.01 46.19 1-2 125 MG, DAILY | 1 0.01 46.20 1-2 TABLETS AT BEDTIME | 1 0.01 46.21 1-3 THREE TIMES DAILY AS NEEDED | 1 0.01 46.22 1-5 MCG/KG/MINUTE | 1 0.01 46.23 1-8MG | 1 0.01 46.24 1.0 G, TWICE DAILY | 1 0.01 46.25 1.2 MG, QD | 1 0.01 46.26 1.25 MG, 1X/DAY | 1 0.01 46.27 1.25 MG, 1X/DAY (IN THE MORNING) | 1 0.01 46.28 1.25 MG, QD | 1 0.01 46.29 1.25 MG, UNK | 2 0.02 46.31 1.25 MUG, QD | 1 0.01 46.32 1.3 MG/M2, UNK | 2 0.02 46.34 1.5 ?G/KG, QW | 1 0.01 46.35 1.5 G PER DAY | 1 0.01 46.36 1.5 G, 2X/DAY | 1 0.01 46.37 1.5 G, QD | 2 0.02 46.39 1.5 G, UNK | 1 0.01 46.40 1.5 G, UNKNOWN | 1 0.01 46.41 1.5 MG, QD | 1 0.01 46.42 1.5 MG, QD (STOP DATE: 25 SEP 2008) | 1 0.01 46.43 1.5 MG, UNK | 4 0.04 46.47 1.5 MG/KG DAILY; | 1 0.01 46.48 1.5 MG/KG, BID | 2 0.02 46.50 1.5 MG/KG, QID | 1 0.01 46.51 1.5 MG/M2, QD | 2 0.02 46.53 1.5 MG/M2, UNK | 4 0.04 46.57 1.5-3MG/DAY | 1 0.01 46.58 1.8 MG, QD | 2 0.02 46.60 1.95 MG, DAILY DOSE | 1 0.01 46.61 10 ?G, BID | 1 0.01 46.62 10 CYCLE | 4 0.04 46.66 10 CYCLES | 2 0.02 46.68 10 DROPS, AS NEEDED | 1 0.01 46.69 10 MG | 9 0.09 46.78 10 MG 2 AT BEDTIME | 1 0.01 46.79 10 MG AS NEEDED EVERY EIGHT HOURS | 2 0.02 46.81 10 MG DAILY DOSE | 2 0.02 46.83 10 MG IN THE MORNING AND 10 IN THE EV.. | 1 0.01 46.84 10 MG, 1X/DAY | 8 0.08 46.92 10 MG, 1X/DAY (1 SUPPOSITORY AS NEEDE.. | 1 0.01 46.93 10 MG, 1X/DAY (IN THE MORNING) | 1 0.01 46.94 10 MG, 2 TIMES/WK | 1 0.01 46.95 10 MG, 2X/DAY (BID) | 1 0.01 46.96 10 MG, 3 TIMES WEEKLY | 1 0.01 46.97 10 MG, 3X/DAY (1 TABLET ORALLY THREE .. | 1 0.01 46.98 10 MG, AS NEEDED | 1 0.01 46.99 10 MG, AS NEEDED (1 TABLET AS NEEDED .. | 1 0.01 47.00 10 MG, BEDTIME | 1 0.01 47.01 10 MG, BID | 9 0.09 47.10 10 MG, BID FOR MANY YEARS | 1 0.01 47.11 10 MG, DAILY | 3 0.03 47.14 10 MG, INTERMITTENT | 1 0.01 47.15 10 MG, ONCE DAILY (QD) | 2 0.02 47.17 10 MG, PRN | 3 0.03 47.20 10 MG, Q12H | 2 0.02 47.22 10 MG, Q4H | 1 0.01 47.23 10 MG, Q6H | 1 0.01 47.24 10 MG, Q6H, PRN | 1 0.01 47.25 10 MG, QD | 65 0.65 47.90 10 MG, QHS | 1 0.01 47.91 10 MG, QMO | 1 0.01 47.92 10 MG, QW | 1 0.01 47.93 10 MG, QWK | 1 0.01 47.94 10 MG, TID | 5 0.05 47.99 10 MG, TID IF NEEDED | 1 0.01 48.00 10 MG, UNK | 51 0.51 48.51 10 MG, UNK (1:30 IN THE MORNING) | 1 0.01 48.52 10 MG, UNKNOWN | 1 0.01 48.53 10 MG/2 ML | 1 0.01 48.54 10 MG/DAY | 2 0.02 48.56 10 MG/KG; MOST RECENT DOSE PRIOR TO S.. | 1 0.01 48.57 10 MG/ML DAILY | 1 0.01 48.58 10 MILLIGRAM DAILY; | 1 0.01 48.59 10 PILLS | 1 0.01 48.60 10 U, EVERY WEEK | 1 0.01 48.61 10 U, UNK | 1 0.01 48.62 10 UNIT EVERY WEEKS (QW) | 1 0.01 48.63 10 UNK, UNK | 1 0.01 48.64 10-0-5 | 1 0.01 48.65 10-12-0.5 MG ORAL DAILY | 1 0.01 48.66 10-20MG DAILY | 1 0.01 48.67 10-325 MG 1 TAB 4X A DAY AS NEEDED | 1 0.01 48.68 10.8 MG, UNK | 9 0.09 48.77 10.92 MG, UNK | 1 0.01 48.78 10/12.5 MG DAILY | 1 0.01 48.79 10/325 - 5 TIMES | 1 0.01 48.80 10/450 MG EVERY 6 HOURS | 1 0.01 48.81 10/500 | 1 0.01 48.82 10/650 | 1 0.01 48.83 100 ?G, QD | 2 0.02 48.85 100 ?G, UNK | 2 0.02 48.87 100 IU/ML (100 UNITS/ML SOLUTION) | 1 0.01 48.88 100 MG | 3 0.03 48.91 100 MG, 1X/DAY | 5 0.05 48.96 100 MG, 2 TIMES/WK | 1 0.01 48.97 100 MG, 2X/DAY | 6 0.06 49.03 100 MG, 2X/DAY (BID) | 1 0.01 49.04 100 MG, 3X/DAY | 2 0.02 49.06 100 MG, AS NEEDED TWICE A DAY | 1 0.01 49.07 100 MG, BID | 11 0.11 49.18 100 MG, DAILY | 2 0.02 49.20 100 MG, DAILY DOSE | 1 0.01 49.21 100 MG, EVERY 12 HOURS | 1 0.01 49.22 100 MG, PRN | 1 0.01 49.23 100 MG, QD | 27 0.27 49.50 100 MG, QID | 1 0.01 49.51 100 MG, TID | 2 0.02 49.53 100 MG, TOTAL | 1 0.01 49.54 100 MG, UNK | 29 0.29 49.83 100 MG/DAY | 1 0.01 49.84 100 MG/M2, QD | 3 0.03 49.87 100 MG/M2, UNK | 3 0.03 49.90 100 ML, 2X/DAY | 1 0.01 49.91 100 ML, TOTAL, , 30 MINUTES BEFORE PA.. | 1 0.01 49.92 100 ML, TOTAL, 30 MINUTES BEFORE PACL.. | 1 0.01 49.93 100 UG | 1 0.01 49.94 100 UG, 1X/DAY | 1 0.01 49.95 100-10 MG/5 ML. ONE TO TWO TABLESPOON.. | 1 0.01 49.96 100/500 MCG | 1 0.01 49.97 100/6 U, BID | 1 0.01 49.98 1000 IU, 1X/DAY | 1 0.01 49.99 1000 IU, 1X/DAY (1 TABLET ONCE A DAY) | 1 0.01 50.00 1000 IU, ONCE DAILY (QD) | 1 0.01 50.01 1000 MG | 2 0.02 50.03 1000 MG DAILY 5 DAYS A WEEK | 1 0.01 50.04 1000 MG (500MG TWO CAPSULES), UNK | 1 0.01 50.05 1000 MG DAILY DOSE | 2 0.02 50.07 1000 MG, 1X/DAY | 1 0.01 50.08 1000 MG, 2X/DAY | 1 0.01 50.09 1000 MG, 2X/DAY (BID) | 1 0.01 50.10 1000 MG, BID | 2 0.02 50.12 1000 MG, DAILY | 1 0.01 50.13 1000 MG, EVERY 12 WEEKS | 1 0.01 50.14 1000 MG, QD | 21 0.21 50.35 1000 MG, QD (DAILY) | 1 0.01 50.36 1000 MG, TID | 1 0.01 50.37 1000 MG, UNK | 7 0.07 50.44 1000 MG/M2, BID | 1 0.01 50.45 1000 MG/M2, UNK | 3 0.03 50.48 1000 UG, UNK | 1 0.01 50.49 1000/GAMMA/MONTH. | 1 0.01 50.50 100000 UNK, 2X/DAY (100000 UNIT/GM PO.. | 1 0.01 50.51 1000MG DAILY | 3 0.03 50.54 1000MG/MQ | 1 0.01 50.55 1003 ML/DAY | 1 0.01 50.56 100MG ONE DURING THE DAY AND ONE AT N.. | 1 0.01 50.57 100MG. PATIENT TOOK 1 PACKET AT 5.30P.. | 1 0.01 50.58 100MG/M2 ON DAY 8 | 7 0.07 50.65 105 MG, UNK | 1 0.01 50.66 10MG DAILY | 1 0.01 50.67 10MG/KG | 1 0.01 50.68 10ML. PATIENT TOOK TWO DOSES. 2 TEASP.. | 1 0.01 50.69 10SEP08 | 1 0.01 50.70 11 NG/KG, PER MIN | 1 0.01 50.71 11.5 G, SINGLE | 1 0.01 50.72 110 MG, UNK | 2 0.02 50.74 110 MG/M2, UNK | 1 0.01 50.75 1100 IU, UNK | 1 0.01 50.76 112MCG DAILY | 1 0.01 50.77 117 MG, UNK | 1 0.01 50.78 1176 MG, UNK | 1 0.01 50.79 11TH INFUSION | 1 0.01 50.80 12 G, QD | 1 0.01 50.81 12 G/M2 (20 G) | 1 0.01 50.82 12 MCG TWICE DAILY | 1 0.01 50.83 12 MG, 7 DAYS ON/7 DAYS OFF | 1 0.01 50.84 12 MG, BID | 5 0.05 50.89 12 MG, QD | 27 0.27 51.16 12 MG, QD FOR 7 DAYS EVERY 4 WEEKS | 1 0.01 51.17 12 MG, TID | 1 0.01 51.18 12 MG, UNK | 3 0.03 51.21 12 MG, UNKNOWN | 1 0.01 51.22 12.5 MG | 1 0.01 51.23 12.5 MG Q HS | 1 0.01 51.24 12.5 MG, 1X/DAY | 1 0.01 51.25 12.5 MG, DAILY (1/D) | 1 0.01 51.26 12.5 MG, HS | 1 0.01 51.27 12.5 MG, QD | 5 0.05 51.32 12.5 MG, TID | 1 0.01 51.33 12.5 MG, UNK | 2 0.02 51.35 12.5 UNITS DAILY | 1 0.01 51.36 120 MG, 1X/DAY | 1 0.01 51.37 120 MG, 2X/DAY | 1 0.01 51.38 120 MG, DAILY | 2 0.02 51.40 120 MG, Q4WK | 1 0.01 51.41 120 MG, QD | 4 0.04 51.45 120 MG, TID | 1 0.01 51.46 120 MUG, QWK | 2 0.02 51.48 1200 MG, 2/D | 1 0.01 51.49 1200 MG, QD | 3 0.03 51.52 1200 MG, UNK | 1 0.01 51.53 1200 MG/M2, UNK | 2 0.02 51.55 122.25 | 1 0.01 51.56 1240 MG, QCYCLE | 1 0.01 51.57 125 MCG, 2X/DAY:BID | 1 0.01 51.58 125 MG | 1 0.01 51.59 125 MG CAPSULE ONCE A DAY FOR 21 DAYS.. | 1 0.01 51.60 125 MG, 1X/DAY | 1 0.01 51.61 125 MG, BID | 3 0.03 51.64 125 MG, ON ALTERNATE DAYS | 1 0.01 51.65 125 MG, QD | 2 0.02 51.67 125 MG, QWK | 1 0.01 51.68 125 MG, UNK | 2 0.02 51.70 125 MILLIGRAM/D THEN 50 MG/D IN THE T.. | 1 0.01 51.71 1250 MG, 1X/DAY | 1 0.01 51.72 1250 MG, BID | 1 0.01 51.73 1250 MG, QD | 2 0.02 51.75 12MG:2009-6OT10,9MG:7-20OT10TD:14DY,6.. | 1 0.01 51.76 130 MG, UNK | 1 0.01 51.77 1300 MG, BID | 1 0.01 51.78 135 MG, BID | 1 0.01 51.79 135 MILLIGRAM DAILY; | 1 0.01 51.80 13AUG12-14AUG12 IV 23JUN12-23JUN12 O.. | 1 0.01 51.81 14 MG | 1 0.01 51.82 14 NG/KG, PER MIN | 1 0.01 51.83 140 MG, UNK | 3 0.03 51.86 145 MG | 1 0.01 51.87 146 MG, UNK | 1 0.01 51.88 146.6 G, TOTAL | 1 0.01 51.89 14SEP-26SEP-150MG,60 MG 26SEP11 TO 29.. | 1 0.01 51.90 15 G, UNK | 1 0.01 51.91 15 MG | 2 0.02 51.93 15 MG, 1X/DAY | 2 0.02 51.95 15 MG, 2X/DAY | 1 0.01 51.96 15 MG, BID | 8 0.08 52.04 15 MG, QD | 61 0.61 52.65 15 MG, QWK | 1 0.01 52.66 15 MG, THREE TIMES WEEKLY | 1 0.01 52.67 15 MG, UNK | 20 0.20 52.87 15 MG, WEEKLY | 1 0.01 52.88 15 MG, WEEKLY (QW) | 1 0.01 52.89 15 MILLIGRAM DAILY; | 1 0.01 52.90 15-22 MG QD AS NEEDED | 1 0.01 52.91 150 ?G, UNK | 2 0.02 52.93 150 MG | 2 0.02 52.95 150 MG /DAY | 1 0.01 52.96 150 MG, 1X/DAY | 4 0.04 53.00 150 MG, 2X/DAY | 5 0.05 53.05 150 MG, 2X/DAY (150 TAKES 1 BID) | 1 0.01 53.06 150 MG, 3X/DAY | 2 0.02 53.08 150 MG, 3X/DAY (75 MG 2 TABS TID) | 1 0.01 53.09 150 MG, 4X/DAY | 1 0.01 53.10 150 MG, BID | 8 0.08 53.18 150 MG, CYCLICAL | 1 0.01 53.19 150 MG, EVERY 8 WEEKS | 3 0.03 53.22 150 MG, EVERY 8TH WEEK | 1 0.01 53.23 150 MG, Q MO | 1 0.01 53.24 150 MG, Q12H | 1 0.01 53.25 150 MG, QD | 8 0.08 53.33 150 MG, QM | 2 0.02 53.35 150 MG, SINGLE (ON DAY 1 ONLY) | 1 0.01 53.36 150 MG, TID | 1 0.01 53.37 150 MG, UNK | 23 0.23 53.60 150 MG, UNKNOWN | 1 0.01 53.61 150 MG/ DAY | 1 0.01 53.62 150 MG/M2, QD | 2 0.02 53.64 150 MG/M2, UNK | 3 0.03 53.67 150 MILLIGRAM DAILY; | 1 0.01 53.68 150 UG, QD | 1 0.01 53.69 150 UG, UNK | 1 0.01 53.70 150-900 MG, 1 MG/MINUTE | 1 0.01 53.71 150/8 MG | 1 0.01 53.72 1500 MG, 1X/DAY:QD | 1 0.01 53.73 1500 MG, DAILY | 2 0.02 53.75 1500 MG, QD | 7 0.07 53.82 1500 MG, UNK | 4 0.04 53.86 1500 MG, UNKNOWN | 2 0.02 53.88 1500 MG, UNKNOWN (DAY) | 1 0.01 53.89 1500 MG/M2, QD | 2 0.02 53.91 1500 MG/M2, UNK | 2 0.02 53.93 1500 UG, UNK | 1 0.01 53.94 1500MG | 1 0.01 53.95 153.8 MG, Q2WK | 1 0.01 53.96 157 MG, TOTAL | 10 0.10 54.06 15AUG12 TO 16AUG12-10MG-SC | 1 0.01 54.07 16 MG, 1 IN 1 DAY | 2 0.02 54.09 16 MG, QD | 2 0.02 54.11 16 MG, UNK | 3 0.03 54.14 16 NG/KG, PER MIN | 1 0.01 54.15 16/125 MG | 1 0.01 54.16 160 /4.5 MCG, TWO PUFFS BID | 2 0.02 54.18 160 4.5 MCG 2 PUFFS BID | 1 0.01 54.19 160 MCG, ONE PUFFS, TWICE DAILY | 3 0.03 54.22 160 MCG, TWO PUFFS, TWICE DAILY | 3 0.03 54.25 160 MG | 2 0.02 54.27 160 MG DAILY | 1 0.01 54.28 160 MG, 1X/DAY | 1 0.01 54.29 160 MG, 2 PUFFS, TWO TIMES A DAY | 1 0.01 54.30 160 MG, BID SA/SU | 1 0.01 54.31 160 MG, QD | 5 0.05 54.36 160 MG, TOTAL | 1 0.01 54.37 160 MG, UNK | 3 0.03 54.40 160 MICROGAMS TWO PUFFS TWICE A DAY | 2 0.02 54.42 160/4.5 2 PUFFS BID | 2 0.02 54.44 160/4.5 MCG 1 PUFF TWICE DAILY | 1 0.01 54.45 160/4.5 MCG 2 PUFFS BID | 1 0.01 54.46 160/4.5 MCG 2 PUFFS, TWO TIMES A DAY | 2 0.02 54.48 160/4.5 MCG DAILY | 2 0.02 54.50 160/4.5 MCG TWO PUFFS, TWICE DAILY | 1 0.01 54.51 160/4.5 MCG TWO TIMES DAILY | 1 0.01 54.52 160/4.5 MCG UNKNOWN | 2 0.02 54.54 160/4.5 MCG, 2 INHALATIONS TWO TIMES .. | 2 0.02 54.56 160/4.5 MCG, 2 PUFFS | 1 0.01 54.57 160/4.5 MCG, TWO PUFFS IN THE MORNING.. | 2 0.02 54.59 160/4.5 MCG, TWO PUFFS TWICE DAILY | 1 0.01 54.60 160/4.5 MCG, TWO PUFFS, TWO TIMES A DAY | 3 0.03 54.63 160/4.5 MCG,TWO TIMES A DAY | 1 0.01 54.64 160/4.5 MICROGRAMS TWO PUFFS TWO TIME.. | 4 0.04 54.68 160/4.5 MICROGRAMS, TWO TIMES A DAY | 1 0.01 54.69 160/4.5 TWO PUFFS TWO TIMES A DAY | 2 0.02 54.71 160/4.5 TWO PUFFS, TWO TIMES A DAY | 3 0.03 54.74 160/4.5 UG 1 PUFF, TWO TIMES A DAY | 1 0.01 54.75 160/4.5 UG 2 PUFFS TWICE A DAY | 3 0.03 54.78 160/4.5 UG, 2 PUFFS TWICE A DAY | 3 0.03 54.81 160/4.5 UG, TWO TIMES A DAY, 1 PUFF I.. | 1 0.01 54.82 160/4.5, TWO PUFFS ONCE A DAY | 1 0.01 54.83 160/4.5MCG ON TWO TIMES A DAY | 2 0.02 54.85 160/4.5MCG TWO PUFFS TWICE DAILY | 2 0.02 54.87 160/4.5MCG, 2 PUFFS BID | 1 0.01 54.88 160MG IN THE MORNING AND 200MG IN THE.. | 1 0.01 54.89 17-JAN 1 + A HALF TAB,18 JAN 1 TAB, 1.. | 1 0.01 54.90 170 MG, UNK | 1 0.01 54.91 175 ?G, QD | 1 0.01 54.92 175 MG/M2, UNK | 5 0.05 54.97 17AUG12-375MG IV | 1 0.01 54.98 18 G, UNK | 1 0.01 54.99 18 IU, UNK | 1 0.01 55.00 18 MCG | 1 0.01 55.01 18 MCG 1 INHALATION | 1 0.01 55.02 18 MG, QD | 12 0.12 55.14 18 MG, TID | 1 0.01 55.15 18 MG, UNK | 1 0.01 55.16 18 ML, QD | 1 0.01 55.17 18-103 MCG/ACT 2 INHALATION EVERY 4 HRS | 1 0.01 55.18 18-20 ML IN THE SUBARCHNOID REGION | 2 0.02 55.20 180 ?G, AS NEEDED (PRN) | 1 0.01 55.21 180 MCG/ACT SOLN INHALATION | 1 0.01 55.22 180 MG, DAILY | 1 0.01 55.23 180 MG, QD | 2 0.02 55.25 180 MG, QWK | 1 0.01 55.26 180 MG, UNK | 1 0.01 55.27 180, TWO INHALATIONS, DAILY | 2 0.02 55.29 18480 MG, TOTAL | 1 0.01 55.30 1900 ?G, UNK | 1 0.01 55.31 192 MG/M2, UNK | 1 0.01 55.32 1DF = 1 CAPS | 1 0.01 55.33 1DF =1 INJECTION STRENGTH:VENOFER 1.. | 1 0.01 55.34 1DF: 10 MG AND 25 MG TABLETS | 1 0.01 55.35 1DF: 10 MG/ML SOLUTION FORMULATION: I.. | 1 0.01 55.36 1DF:50 UNIT NOS | 1 0.01 55.37 1DF= 2X187.8MG | 1 0.01 55.38 1DF= 3US10MG/KG. LAST DOSE ON 31AUG12. | 1 0.01 55.39 1DF= 400 UI | 1 0.01 55.40 1DF= 5G/M3 | 5 0.05 55.45 1DF= 5G/M3 4 CYCLES | 2 0.02 55.47 1DF=1 DOSE | 1 0.01 55.48 1DF=100 MG/12.5 MG/ML(AMOXICILLIN/CLA.. | 1 0.01 55.49 1DF=2 DOSES | 1 0.01 55.50 1DF=2UNS | 1 0.01 55.51 1DF=300UI/KG | 1 0.01 55.52 1DF=4 X 80MG | 1 0.01 55.53 1DOSAGE FORM=12 500 IU/0.5ML. | 1 0.01 55.54 1DOSE | 1 0.01 55.55 1MG AS NEEDED TID | 1 0.01 55.56 1MG IN AM 1 MG IN AFTERNOON 2 MG AT N.. | 2 0.02 55.58 1MG, EVERY 6 HOURS, AS NEEDED | 1 0.01 55.59 1MG/2ML, 1 BID | 1 0.01 55.60 1ST RPAP DOSE | 1 0.01 55.61 2 CAP, QID | 1 0.01 55.62 2 CAPLETS AT BEDTIME | 1 0.01 55.63 2 CAPSULES AT BEDTIME | 1 0.01 55.64 2 CAPSULES DAILY | 1 0.01 55.65 2 DF, 1D | 1 0.01 55.66 2 DF, 2X/DAY | 1 0.01 55.67 2 DF, BID | 1 0.01 55.68 2 DF, QD | 7 0.07 55.75 2 DF, TID | 1 0.01 55.76 2 DF, UNK | 2 0.02 55.78 2 DOSES | 4 0.04 55.82 2 G DAILY DOSE | 1 0.01 55.83 2 G, BID | 1 0.01 55.84 2 G, INTERMITTENT | 2 0.02 55.86 2 G, QD | 4 0.04 55.90 2 G, TID | 2 0.02 55.92 2 G, UNK | 3 0.03 55.95 2 GTT, BID | 1 0.01 55.96 2 MG 1 TABLET, AS NEEDED TWICE A DAY | 1 0.01 55.97 2 MG TABLET BEFORE SLEEP | 1 0.01 55.98 2 MG, 1X/DAY | 2 0.02 56.00 2 MG, 2X/DAY | 1 0.01 56.01 2 MG, 3X/DAY | 1 0.01 56.02 2 MG, BID | 5 0.05 56.07 2 MG, ONCE DAILY (QD) | 1 0.01 56.08 2 MG, PRN | 1 0.01 56.09 2 MG, QD | 8 0.08 56.17 2 MG, QMO | 1 0.01 56.18 2 MG, UNK | 9 0.09 56.27 2 MG, UNK (AT ABOUT 2:00 O'CLOCK AND .. | 1 0.01 56.28 2 MG/2ML, 1 IN 2 HOURS, AS NEEDED | 1 0.01 56.29 2 MG/DAY | 1 0.01 56.30 2 MILLION KIU LOADING DOSE, THEN 500,.. | 1 0.01 56.31 2 ML, QD | 1 0.01 56.32 2 ML, UNK | 1 0.01 56.33 2 OT, 2 UNITS EVERY THREE AND HALF DAYS | 1 0.01 56.34 2 OT, UNK | 1 0.01 56.35 2 PUFF | 1 0.01 56.36 2 PUFF(S), *2D, 220MCG | 1 0.01 56.37 2 PUFF(S), BID, 110 MCG | 1 0.01 56.38 2 PUFF(S), VA | 1 0.01 56.39 2 PUFFS AS NEEDED. | 1 0.01 56.40 2 PUFFS TWICE DAILY | 1 0.01 56.41 2 SPRAYS PER NOSTRIL DAILY | 1 0.01 56.42 2 TAB, QD | 1 0.01 56.43 2 TABLET ORAL ONCE DAY | 1 0.01 56.44 2 TABLETS | 1 0.01 56.45 2 TABLETS 4 TIMES A DAY AS NEEDED EVE.. | 1 0.01 56.46 2 TABLETS, BID | 1 0.01 56.47 2 TABS MWFS AND 1 ON TTS | 1 0.01 56.48 2 TABS ON MTUWTHF AND 1 TAB ST | 1 0.01 56.49 2 TEA SPOONS-MRNG AND 2 TEA SPOONS-EVE. | 1 0.01 56.50 2 U, BIW | 1 0.01 56.51 2 U, EVERY 1-2 WEEKS | 1 0.01 56.52 2 U, EVERY 2 WEEK | 1 0.01 56.53 2 U, EVERY 2 WEEKS | 2 0.02 56.55 2 U, QW | 2 0.02 56.57 2 U, QW2 | 1 0.01 56.58 2 U, QW3 | 1 0.01 56.59 2 U, UNK | 1 0.01 56.60 2 UNITS, QW (EVERY WEEK) | 1 0.01 56.61 2 UNK | 2 0.02 56.63 2-6MG | 1 0.01 56.64 2.1 G, BID | 1 0.01 56.65 2.1 G, QD | 1 0.01 56.66 2.25 MG, QD | 1 0.01 56.67 2.5 G, QD | 1 0.01 56.68 2.5 MG | 1 0.01 56.69 2.5 MG (1.5 MG (QAM) AND 1 MG (QPM)) | 1 0.01 56.70 2.5 MG / DAY | 1 0.01 56.71 2.5 MG CAPSULE WITH IBRANCE FOR 21 DA.. | 1 0.01 56.72 2.5 MG QH-6H | 1 0.01 56.73 2.5 MG, / DAY | 1 0.01 56.74 2.5 MG, 2X/DAY | 1 0.01 56.75 2.5 MG, ONCE DAILY (QD) | 1 0.01 56.76 2.5 MG, ONSET OF MIGRAINE | 1 0.01 56.77 2.5 MG, QD | 25 0.25 57.02 2.5 MG, QD (DAILY) | 1 0.01 57.03 2.5 MG, QWK | 1 0.01 57.04 2.5 MG, UNK | 13 0.13 57.17 2.5 MG/3 ML 0.083% NEBULIZATION 1 INH.. | 1 0.01 57.18 2.5 ML OF HEAVY 0.5% | 1 0.01 57.19 2.5 MUG, 3 TIMES/WK -15 TIME EXECUTION | 1 0.01 57.20 2.5-0.025 MG DAILY | 1 0.01 57.21 2.5/0.5MG/3ML | 1 0.01 57.22 2.50 UG, UNK | 1 0.01 57.23 2.52 MG, UNK | 1 0.01 57.24 2/500 MG,1D | 1 0.01 57.25 20 G, UNK | 1 0.01 57.26 20 GTT, QD | 2 0.02 57.28 20 IU, PER DAY | 1 0.01 57.29 20 MCG/24HR, CONT | 4 0.04 57.33 20 MEQ, DAILY | 2 0.02 57.35 20 MG | 6 0.06 57.41 20 MG IN 500 ML 0.9% NACL INFUSED AT .. | 2 0.02 57.43 20 MG QD | 1 0.01 57.44 20 MG, | 1 0.01 57.45 20 MG, 1X/DAY | 9 0.09 57.54 20 MG, 1X/DAY(1 CAPSULE IN THE MORNIN.. | 1 0.01 57.55 20 MG, 2/D | 1 0.01 57.56 20 MG, 2X/DAY | 5 0.05 57.61 20 MG, BID | 3 0.03 57.64 20 MG, DAILY | 2 0.02 57.66 20 MG, DAILY DOSE | 1 0.01 57.67 20 MG, ONCE DAILY (QD) | 2 0.02 57.69 20 MG, ONE TABLET ONCE DAILY, OR TWO .. | 1 0.01 57.70 20 MG, QD | 64 0.64 58.34 20 MG, QD (DAILY) | 1 0.01 58.35 20 MG, QD (STOP DATE: 25 SEP 2008) | 1 0.01 58.36 20 MG, QID | 1 0.01 58.37 20 MG, QMO | 1 0.01 58.38 20 MG, QMO (EVERY 4 WEEKS) | 3 0.03 58.41 20 MG, QWK | 2 0.02 58.43 20 MG, TID | 1 0.01 58.44 20 MG, U | 2 0.02 58.46 20 MG, UNK | 31 0.31 58.77 20 MG, UNKNOWN | 1 0.01 58.78 20 MG/D | 1 0.01 58.79 20 MG/DAY | 1 0.01 58.80 20 MG/M2, QCYCLE | 1 0.01 58.81 20 MILLIGRAM DAILY; | 1 0.01 58.82 20 NG/KG, PER MIN | 1 0.01 58.83 20 U, TID | 1 0.01 58.84 20 UG, QD | 3 0.03 58.87 20 UG, UNKNOWN | 2 0.02 58.89 20 UNITS, SINGLE | 2 0.02 58.91 20.12.5 MG | 1 0.01 58.92 20/FEB/2007, 21/FEB/2007, 22/FEB/2007.. | 1 0.01 58.93 200 ?G, UNK | 1 0.01 58.94 200 MG | 3 0.03 58.97 200 MG (DAILY DOSE), BID, | 1 0.01 58.98 200 MG II TABLETS ORALLY IN EVENING | 1 0.01 58.99 200 MG, 1X/DAY | 4 0.04 59.03 200 MG, 1X/DAY (ONCE IN AM) | 2 0.02 59.05 200 MG, 2X/DAY | 5 0.05 59.10 200 MG, 2X/DAY (BID) | 1 0.01 59.11 200 MG, 3X/DAY | 1 0.01 59.12 200 MG, BID | 7 0.07 59.19 200 MG, CUMULATIVE DOSE: 1200MG | 1 0.01 59.20 200 MG, EV 2 WEEKS(QOW) | 6 0.06 59.26 200 MG, PRN | 2 0.02 59.28 200 MG, QD | 18 0.18 59.46 200 MG, QOD | 1 0.01 59.47 200 MG, TID | 1 0.01 59.48 200 MG, UNK | 17 0.17 59.65 200 MG/M2, Q2WK | 1 0.01 59.66 200 MG/M2, Q3WK | 1 0.01 59.67 200 MG/M2, QD | 49 0.49 60.16 200 MG/M2,QD | 1 0.01 60.17 200 UG, QD | 1 0.01 60.18 200 UG, UNK | 1 0.01 60.19 200-5 MCG/ACT 2 INHALATION | 1 0.01 60.20 2000 IU, UNK | 1 0.01 60.21 2000 MG, CYCLICAL | 1 0.01 60.22 2000 MG, QD | 7 0.07 60.29 2000 MG, UNKNOWN | 1 0.01 60.30 2000 MG/M2 | 1 0.01 60.31 2000 MG/M2 DAILY; DAY 1 TO 14, EVERY .. | 1 0.01 60.32 2000 MG/M2 TWO HOUR INFUSION | 1 0.01 60.33 2000 UNITS DAILY | 1 0.01 60.34 20000 MG, 1X/DAY | 1 0.01 60.35 200MG ONCE AT NIGHT | 1 0.01 60.36 200MG TWICE A MONTH | 1 0.01 60.37 20MG | 2 0.02 60.39 21 MG, QD | 2 0.02 60.41 21-21MAY2012,11-11JUN2012 | 1 0.01 60.42 210 MG, BID | 1 0.01 60.43 2160 MG, UNK | 1 0.01 60.44 22 NG/KG, PER MIN | 1 0.01 60.45 22 U, 30 MINTUES BEFORE BREAKFAST AND.. | 1 0.01 60.46 22.5 MG, QD | 2 0.02 60.48 220 MCG, 1-2 PUFFS AT BEDTIME TO TWIC.. | 1 0.01 60.49 220 MG | 3 0.03 60.52 220 MG, QD | 1 0.01 60.53 2237 MCG/DAY | 1 0.01 60.54 225 MG, 2X/DAY | 1 0.01 60.55 225 MG, QD | 1 0.01 60.56 2250 MG, 1X/DAY:QD | 1 0.01 60.57 2250 MG, QD | 1 0.01 60.58 2250 MG, UNKNOWN (DAY) | 1 0.01 60.59 23NOV2010. | 1 0.01 60.60 24 DF, CO | 1 0.01 60.61 24 IU IN MORNING,30 IU IN EVENING | 1 0.01 60.62 24 MG, AS NEEDED | 1 0.01 60.63 24 MG, DAILY | 2 0.02 60.65 24 MG, QD | 10 0.10 60.75 24 MG, TID | 1 0.01 60.76 24 MG, UNK | 1 0.01 60.77 24.8 G, TOTAL | 1 0.01 60.78 2400 MG, QD | 1 0.01 60.79 2400 MG, UNK | 1 0.01 60.80 24000 UNIT CPEP 1-2 BEFORE MEALS | 1 0.01 60.81 240MG 35 AND 38 WEEK | 1 0.01 60.82 245 MG, QD | 2 0.02 60.84 24JUN12-25JUN12:50MG 26JUN12-08JUL12.. | 1 0.01 60.85 25 IU, 1X/DAY | 1 0.01 60.86 25 MG | 4 0.04 60.90 25 MG (SPLITTING A 50 MG TABLET) EVER.. | 2 0.02 60.92 25 MG (TAKES HALF TABLET), ONCE | 1 0.01 60.93 25 MG DAILY GENERIC, DR.REDDYS | 1 0.01 60.94 25 MG, 1X/DAY | 2 0.02 60.96 25 MG, 1X/DAY:QD | 1 0.01 60.97 25 MG, 2 TIMES/WK | 16 0.16 61.13 25 MG, 2X/DAY | 1 0.01 61.14 25 MG, 3 TIMES/WK | 1 0.01 61.15 25 MG, 3X/DAY | 1 0.01 61.16 25 MG, AT BEDTIME | 1 0.01 61.17 25 MG, BID | 3 0.03 61.20 25 MG, DAILY | 2 0.02 61.22 25 MG, INTERMITTENT | 1 0.01 61.23 25 MG, ONCE DAILY (QD) | 2 0.02 61.25 25 MG, PRN | 1 0.01 61.26 25 MG, PRN (AS NEEDED) | 1 0.01 61.27 25 MG, QAM | 1 0.01 61.28 25 MG, QD | 14 0.14 61.42 25 MG, QD PRN | 1 0.01 61.43 25 MG, QWK | 5 0.05 61.48 25 MG, SINGLE | 2 0.02 61.50 25 MG, TABS. 1.5 TAB DAILY | 1 0.01 61.51 25 MG, TID | 1 0.01 61.52 25 MG, TWICE A WEEK | 1 0.01 61.53 25 MG, U | 1 0.01 61.54 25 MG, UNK | 17 0.17 61.71 25 MG, UNK (AT 11:00 O'CLOCK IN THE M.. | 1 0.01 61.72 25 MG, UNK (ONCE A DAY OR TWICE A DAY) | 1 0.01 61.73 25 MG, WEEKLY | 1 0.01 61.74 25 MG, WEEKLY (QW) | 1 0.01 61.75 25 MG/DAY | 1 0.01 61.76 25 MG/M2, QD | 1 0.01 61.77 25 MGS IN AFTERNOON | 2 0.02 61.79 25 MICROGRAM DAILY; | 1 0.01 61.80 25-150 MG DAILY TO TWICE DAILY | 1 0.01 61.81 25/100 MG TID | 1 0.01 61.82 250 ?G, QOD | 1 0.01 61.83 250 MCG/ML | 1 0.01 61.84 250 MG DAILY | 1 0.01 61.85 250 MG, 1X/DAY | 1 0.01 61.86 250 MG, 2X/DAY | 6 0.06 61.92 250 MG, 3X/DAY | 1 0.01 61.93 250 MG, BID | 2 0.02 61.95 250 MG, CYCLIC (TWICE DAILY) | 1 0.01 61.96 250 MG, QD | 11 0.11 62.07 250 MG, QD (DAILY) | 1 0.01 62.08 250 MG, QID | 2 0.02 62.10 250 MG, TID | 4 0.04 62.14 250 MG, UNK | 5 0.05 62.19 250 ML, ONCE | 1 0.01 62.20 250 ML, TOTAL | 10 0.10 62.30 250 UG, UNK | 1 0.01 62.31 250 UNK, UNK | 1 0.01 62.32 250/25 2 PUFFS | 1 0.01 62.33 250/50 | 2 0.02 62.35 250/50 MCG UNK | 1 0.01 62.36 250/50 ONE PUFF PO BID | 1 0.01 62.37 2500 MG, QD | 4 0.04 62.41 26 PER CYCLE | 2 0.02 62.43 2600 MG, QD | 2 0.02 62.45 265 MG, QD | 1 0.01 62.46 27 NG/KG, PER MIN | 1 0.01 62.47 270 MG, ADJUVANT 150-200 MG/M2/D, (EV.. | 1 0.01 62.48 270 MG, UNK | 1 0.01 62.49 275 MG, BID | 1 0.01 62.50 28 DAYS | 1 0.01 62.51 280 MG, 2X/DAY | 1 0.01 62.52 2A/DAY | 1 0.01 62.53 2MG/DIE | 1 0.01 62.54 2ND TREATMENT | 1 0.01 62.55 2X 25 MG WITH ONE HOUR INTERVAL | 1 0.01 62.56 2X/DAY | 1 0.01 62.57 3 / 1DAYS | 1 0.01 62.58 3 CYCLES | 2 0.02 62.60 3 DAYS | 2 0.02 62.62 3 DAYS, EVERY 28 DAYS 3 CYCLES | 1 0.01 62.63 3 DF, BID | 2 0.02 62.65 3 DF, QD | 2 0.02 62.67 3 DF, UNK | 2 0.02 62.69 3 DF, UNKNOWN | 1 0.01 62.70 3 G | 1 0.01 62.71 3 G BID | 1 0.01 62.72 3 G, QD | 3 0.03 62.75 3 G, UNK | 3 0.03 62.78 3 G/DAY | 1 0.01 62.79 3 MG | 1 0.01 62.80 3 MG ONCE A MONTH | 1 0.01 62.81 3 MG, BID | 3 0.03 62.84 3 MG, QD | 18 0.18 63.02 3 MG, UNK | 1 0.01 63.03 3 MG,QD | 1 0.01 63.04 3 MG/KG, Q3WK | 1 0.01 63.05 3 SACHETS 3 TIMES A DAY | 2 0.02 63.07 3 TABLETS | 1 0.01 63.08 3 TABLETS IN MORNING, 2 TABLETS AT BE.. | 1 0.01 63.09 3 TABS AT BED TIME FILL DATE STATUS: .. | 1 0.01 63.10 3 TO 4.5MU | 1 0.01 63.11 3.0 MG, QD | 1 0.01 63.12 3.125-6.25 MG TWICE DAILY | 1 0.01 63.13 3.2 G/M2, Q12H | 2 0.02 63.15 3.25 MG, QD | 1 0.01 63.16 3.5 MG, BID | 1 0.01 63.17 3.5 MG, QD | 4 0.04 63.21 3.5 MG, UNK | 1 0.01 63.22 3.6 MG, UNK | 4 0.04 63.26 3.75 MG, QD | 2 0.02 63.28 3.75 MG, UNK | 1 0.01 63.29 30 ?G, QWK | 1 0.01 63.30 30 GTT, UNK | 1 0.01 63.31 30 IU, 1X/DAY | 1 0.01 63.32 30 MG | 1 0.01 63.33 30 MG, 1X/DAY | 3 0.03 63.36 30 MG, 2X/DAY (BID) | 1 0.01 63.37 30 MG, AT BEDTIME | 1 0.01 63.38 30 MG, BID | 3 0.03 63.41 30 MG, DAILY | 1 0.01 63.42 30 MG, ONCE DAILY (QD) | 1 0.01 63.43 30 MG, QD | 27 0.27 63.70 30 MG, QMO | 4 0.04 63.74 30 MG, QMO (EVERY 4 WEEKS) | 5 0.05 63.79 30 MG, QOD | 1 0.01 63.80 30 MG, TID | 1 0.01 63.81 30 MG, UNK | 20 0.20 64.01 30 ML (DAILY DOSE), PRN, ORAL | 1 0.01 64.02 30 ML, PRN | 1 0.01 64.03 30 ML, QD | 1 0.01 64.04 30 U, EACH EVENING | 2 0.02 64.06 30 UNITS DAILY | 1 0.01 64.07 300 ?G, UNK | 1 0.01 64.08 300 MCG | 1 0.01 64.09 300 MG | 6 0.06 64.15 300 MG, 1X/DAY | 2 0.02 64.17 300 MG, 2X/DAY | 2 0.02 64.19 300 MG, 2X/DAY (300 MG TAKEN AS 50MG,.. | 1 0.01 64.20 300 MG, 3X/DAY | 2 0.02 64.22 300 MG, AT NIGHT | 1 0.01 64.23 300 MG, AT NOON | 1 0.01 64.24 300 MG, BID | 5 0.05 64.29 300 MG, DAILY | 3 0.03 64.32 300 MG, EACH MORNING | 1 0.01 64.33 300 MG, QD | 22 0.22 64.55 300 MG, QD (ONCE DAILY) | 1 0.01 64.56 300 MG, TID | 2 0.02 64.58 300 MG, UNK | 16 0.16 64.74 300 MG/DAY | 2 0.02 64.76 300 MG/M2, UNK | 8 0.08 64.84 300-12.5 MG | 1 0.01 64.85 300-30 MG ONE TABLET, 3X/DAY (EVERY 8.. | 1 0.01 64.86 3000 IU, Q2WK | 1 0.01 64.87 3000 MG, QD | 1 0.01 64.88 3000 MG, UNKNOWN | 3 0.03 64.91 3000 ML, UNK | 1 0.01 64.92 30MG:12MAR-1AP10(18D),24MG:11MAR10,2A.. | 1 0.01 64.93 310 MG, QCYCLE | 1 0.01 64.94 32 G, SINGLE | 1 0.01 64.95 32 MG, UNK | 1 0.01 64.96 320 | 1 0.01 64.97 320 MCGS, TWO TIMES A DAY | 1 0.01 64.98 320 MG, UNK | 1 0.01 64.99 320 MG, UNKNOWN | 1 0.01 65.00 320 MICROGRAMS, TWO TIMES A DAY | 1 0.01 65.01 320 UG TWICE A MONTH | 2 0.02 65.03 320 UG, BID (160/4.5MCG) | 1 0.01 65.04 320/9 MCG, TWO TIMES A DAY | 2 0.02 65.06 322 UNK, UNK | 1 0.01 65.07 325 1/2 | 1 0.01 65.08 325 MG, QD | 1 0.01 65.09 33 MG, EVERY 8 WEEKS | 1 0.01 65.10 330 MG, UNK | 2 0.02 65.12 34UNITS-0WEEK OF INTRAUTERINE PERIOD .. | 1 0.01 65.13 35 MG, QD | 2 0.02 65.15 35 MG, QW | 1 0.01 65.16 35 MG, QWK | 1 0.01 65.17 35 MG, UNK | 1 0.01 65.18 35 MG, WEEKLY | 2 0.02 65.20 35 UG/HR, EVERY THIRD DAY | 1 0.01 65.21 350 MG, 3X/DAY | 1 0.01 65.22 350 MG, UNK | 1 0.01 65.23 360 MG AT NIGHT | 1 0.01 65.24 360 MG, UNK | 2 0.02 65.26 360 MG/M2, UNK | 1 0.01 65.27 3600 MG, QD | 1 0.01 65.28 37.5 MG 1 TABLET, 1X/DAY | 1 0.01 65.29 37.5 MG, 1X/DAY | 1 0.01 65.30 37.5 MG, 3X/DAY | 1 0.01 65.31 37.5-25 , DAILY | 1 0.01 65.32 37.5-25 MG DAILY | 1 0.01 65.33 375 MG, QD | 1 0.01 65.34 375 MG/M2, EVERY 4 WEEKS | 1 0.01 65.35 375 MG/M2, QMONTH | 1 0.01 65.36 375 MG/M2, UNK | 2 0.02 65.38 3MAR09 WITHDRAWN FROM STUDY | 2 0.02 65.40 4 CYCLES | 1 0.01 65.41 4 DF OF 150 MG, QD | 1 0.01 65.42 4 DF, QD | 2 0.02 65.44 4 DF, UNK | 1 0.01 65.45 4 DF/DAY | 1 0.01 65.46 4 DOSAGE FORM= 4 DOSE OF 250MG | 1 0.01 65.47 4 DOSES RECEIVED | 1 0.01 65.48 4 G, QD | 1 0.01 65.49 4 G, QID | 1 0.01 65.50 4 G, TID | 6 0.06 65.56 4 GTT, BID | 1 0.01 65.57 4 GTT, QD | 1 0.01 65.58 4 MG | 1 0.01 65.59 4 MG DAILY IN THE MORNING AND 8 MG DA.. | 1 0.01 65.60 4 MG IN THE MORNING AND 8 MG AT HS. | 1 0.01 65.61 4 MG ONCE A MONTH | 1 0.01 65.62 4 MG, 1 TABLET ON THE TONGUE AND ALLO.. | 1 0.01 65.63 4 MG, 1D | 5 0.05 65.68 4 MG, 1X/DAY, (2 MG 2 CAPS Q HS) | 1 0.01 65.69 4 MG, 2X/DAY | 1 0.01 65.70 4 MG, AS NEEDED | 2 0.02 65.72 4 MG, BEDTIME | 1 0.01 65.73 4 MG, BID | 5 0.05 65.78 4 MG, DAILY | 2 0.02 65.80 4 MG, PRN | 1 0.01 65.81 4 MG, QD | 10 0.10 65.91 4 MG, QD (STOP DATE: 25 SEP 2008) | 1 0.01 65.92 4 MG, UNK | 21 0.21 66.13 4 MG/DAY | 1 0.01 66.14 4 MG/KG (TOTAL OF 54 MG) EVERY 6 WEEKS | 1 0.01 66.15 4 ML, QD | 1 0.01 66.16 4 TAB TWICE DAILY 2 WEEKS ON 1 WEEK OFF | 1 0.01 66.17 4 TABLETS DAILY | 1 0.01 66.18 4 UNITS EVERY FOUR WEEKS | 1 0.01 66.19 4-1000 MG | 1 0.01 66.20 4-2 MG | 1 0.01 66.21 4.5 G, 4X/DAY | 1 0.01 66.22 4.5 G, UNK | 2 0.02 66.24 4.5 MG, QD | 4 0.04 66.28 4.5 ML, UNK | 1 0.01 66.29 40 MG | 3 0.03 66.32 40 MG (DAILY DOSE), , ORAL | 1 0.01 66.33 40 MG (ONE AND A HALF TABLETS AT NIGHT) | 1 0.01 66.34 40 MG AT BEDTIME | 1 0.01 66.35 40 MG DAILY DOSE | 1 0.01 66.36 40 MG IN EACH SIDE OF GLUTES | 1 0.01 66.37 40 MG QD | 1 0.01 66.38 40 MG, 1D | 1 0.01 66.39 40 MG, 1X/DAY | 7 0.07 66.46 40 MG, 1X/DAY (1 TABLET ORALLY ONCE A.. | 1 0.01 66.47 40 MG, 2X/DAY | 1 0.01 66.48 40 MG, BID | 5 0.05 66.53 40 MG, DAILY | 1 0.01 66.54 40 MG, DAILY (2 TABLET DAILY) | 1 0.01 66.55 40 MG, PACKET DAILY | 3 0.03 66.58 40 MG, Q12H | 1 0.01 66.59 40 MG, Q2WK | 1 0.01 66.60 40 MG, QAM | 1 0.01 66.61 40 MG, QD | 20 0.20 66.81 40 MG, QMO (EVERY 4 WEEK) | 1 0.01 66.82 40 MG, QMO (EVERY 4 WEEKS) | 1 0.01 66.83 40 MG, QOD | 1 0.01 66.84 40 MG, U | 1 0.01 66.85 40 MG, UNK | 21 0.21 67.06 40 MG/DAY | 2 0.02 67.08 40 MG/M2, UNK | 6 0.06 67.14 40 ML PER DAY | 1 0.01 67.15 40 UNITS UNDER THE SKIN AT BEDTIME | 1 0.01 67.16 40 UNK, CO | 1 0.01 67.17 40/12.5 MG, UNK, ONCE DAILY | 1 0.01 67.18 400 IU, QD | 1 0.01 67.19 400 MCG | 1 0.01 67.20 400 MG | 4 0.04 67.24 400 MG EVERY OTHER WEEK | 1 0.01 67.25 400 MG, 1X/DAY | 2 0.02 67.27 400 MG, BID | 7 0.07 67.34 400 MG, DAILY | 1 0.01 67.35 400 MG, EV 2 WEEKS(QOW) | 2 0.02 67.37 400 MG, EV 4 WEEKS | 1 0.01 67.38 400 MG, QD | 39 0.39 67.77 400 MG, QD (ONCE DAILY) | 1 0.01 67.78 400 MG, UNK | 7 0.07 67.85 400 MG/M2, UNK | 2 0.02 67.87 4000 IU, 2X/DAY | 1 0.01 67.88 40000 IU, WEEKLY | 1 0.01 67.89 400MCG/MQ | 1 0.01 67.90 40MG DAILY | 1 0.01 67.91 40MG DAILY AS NEEDED | 1 0.01 67.92 41 NG/KG, PER MIN | 1 0.01 67.93 44 ?G, 3 TIMES/WK | 2 0.02 67.95 44 NG/KG/MIN CONTINOUS | 2 0.02 67.97 44 NG/KG/MIN CONTINUOUS | 1 0.01 67.98 45 MG, UNK | 6 0.06 68.04 45 MG/M2, UNK | 1 0.01 68.05 450 MG AT NIGHT | 1 0.01 68.06 450 MG, QD | 3 0.03 68.09 450 MG, UNK | 2 0.02 68.11 46 NG/KG/MIN AT 60,000 NG/ML | 1 0.01 68.12 47.5 MG, QD | 1 0.01 68.13 47.5 MG, UNK | 1 0.01 68.14 48 NG/KG/MIN | 1 0.01 68.15 480 MG, UNK | 1 0.01 68.16 480 UG | 1 0.01 68.17 49 UNK, CO | 1 0.01 68.18 4MG/500MG, BID | 1 0.01 68.19 4X100 MG | 1 0.01 68.20 5 % DAILY | 1 0.01 68.21 5 AUC OVER 15 MINUTES ON DAY 1 | 1 0.01 68.22 5 AUC OVER 15 MINUTES ON DAY 1 | 1 0.01 68.23 5 DAYS | 2 0.02 68.25 5 DAYS, 4 CYCLES | 1 0.01 68.26 5 GTT, QD | 2 0.02 68.28 5 IU, UNK | 1 0.01 68.29 5 MG | 8 0.08 68.37 5 MG PER 100 ML, YEARLY | 1 0.01 68.38 5 MG PER DAY | 1 0.01 68.39 5 MG QD | 2 0.02 68.41 5 MG TABLETS. 1 X 5 MG AND THE NEXT D.. | 1 0.01 68.42 5 MG, 1X/DAY | 6 0.06 68.48 5 MG, 1X/DAY AT BEDTIME | 1 0.01 68.49 5 MG, 2X/DAY | 1 0.01 68.50 5 MG, BID | 1 0.01 68.51 5 MG, INTERMITTENT | 1 0.01 68.52 5 MG, ONCE DAILY (QD) | 3 0.03 68.55 5 MG, PRN | 2 0.02 68.57 5 MG, Q 4 HRS PM AS NEEDED | 1 0.01 68.58 5 MG, Q5H | 1 0.01 68.59 5 MG, QD | 58 0.58 69.17 5 MG, QD (STOP DATE: 25 SEP 2008) | 1 0.01 69.18 5 MG, QOD | 1 0.01 69.19 5 MG, QWK | 1 0.01 69.20 5 MG, TID | 2 0.02 69.22 5 MG, UNK | 73 0.73 69.95 5 MG, UNKNOWN | 1 0.01 69.96 5 MG, WEEKLY | 1 0.01 69.97 5 MG/DAY | 1 0.01 69.98 5 MG/KG DAILY; | 1 0.01 69.99 5 MG/KG, QD | 1 0.01 70.00 5 MILLION IU, UNK | 1 0.01 70.01 5 U, AS NEEDED | 1 0.01 70.02 5 UG, 1X/DAY | 1 0.01 70.03 5 UG/KG | 1 0.01 70.04 5-10 MG DAILY | 1 0.01 70.05 5-325 MG | 1 0.01 70.06 5-325MG?TAKE 1 OR 2 TABS EVERY 4-6 HR.. | 1 0.01 70.07 5-500 MG | 2 0.02 70.09 5-500 MG, AS NEEDED (5-500 MG CAPSULE.. | 1 0.01 70.10 5-8 UNITS, MEALS | 1 0.01 70.11 5/500MG EVERY 6 HOURS AS NEEDED | 1 0.01 70.12 50 ?G, | 1 0.01 70.13 50 ?G, QD | 1 0.01 70.14 50 ?G, UNK | 3 0.03 70.17 50 AND OVER 1 TABLET ORAL DAILY | 1 0.01 70.18 50 MCG, QD | 1 0.01 70.19 50 MCG/24HR, UNK | 1 0.01 70.20 50 MG | 1 0.01 70.21 50 MG (DAILY DOSE), QD, INTRAVENOUS | 1 0.01 70.22 50 MG 1/2 TABLET | 1 0.01 70.23 50 MG AT 6 PM 100 MG LATER AT NIGHT | 1 0.01 70.24 50 MG PER DAY | 1 0.01 70.25 50 MG TO 300 MG/DAY | 1 0.01 70.26 50 MG TWICE A DAY MORNING AND NIGHT | 1 0.01 70.27 50 MG, 1X/DAY | 14 0.14 70.41 50 MG, 1X/DAY (AT NIGHT) | 1 0.01 70.42 50 MG, 1X/DAY AT BEDTIME | 1 0.01 70.43 50 MG, 2 TABLETS IN THE AM AND 3 AT N.. | 1 0.01 70.44 50 MG, 2 TIMES/WK | 11 0.11 70.55 50 MG, 28 DAYS INTAKE/14 DAYS PAUSE | 1 0.01 70.56 50 MG, 2X/DAY | 1 0.01 70.57 50 MG, 3X/DAY | 3 0.03 70.60 50 MG, 4X/DAY | 1 0.01 70.61 50 MG, AS NEEDED | 1 0.01 70.62 50 MG, BID | 7 0.07 70.69 50 MG, CYCLE 4X1 | 1 0.01 70.70 50 MG, EACH EVENING | 1 0.01 70.71 50 MG, ONCE A WEEK | 1 0.01 70.72 50 MG, ONCE IN THE MORNING AND ONCE A.. | 2 0.02 70.74 50 MG, ONCE WEEK | 1 0.01 70.75 50 MG, ONCE WEEKLY | 2 0.02 70.77 50 MG, PRN | 2 0.02 70.79 50 MG, PRN (AS NEEDED) | 1 0.01 70.80 50 MG, Q2WK | 2 0.02 70.82 50 MG, Q6WK | 1 0.01 70.83 50 MG, QD | 33 0.33 71.16 50 MG, QWK | 76 0.76 71.92 50 MG, TID | 6 0.06 71.98 50 MG, TWICE A WEEK | 1 0.01 71.99 50 MG, UNK | 25 0.25 72.24 50 MG, WEEKLY | 12 0.12 72.36 50 MG,TID | 1 0.01 72.37 50 MG/M2, UNK | 4 0.04 72.41 50 TO 300 MG/DAY | 1 0.01 72.42 50 U, EACH MORNING | 1 0.01 72.43 50 UG, 1X/DAY | 1 0.01 72.44 50 UG, DAILY (25 MCG, 2 (TWO) TABLET,.. | 1 0.01 72.45 50 UG/ACT DAILY | 1 0.01 72.46 50 UNK, QD | 1 0.01 72.47 50 UNK, QWK | 1 0.01 72.48 50-100 X 3 | 1 0.01 72.49 50-100MG/DIE | 1 0.01 72.50 50-12.5 MG | 1 0.01 72.51 50-25 MG | 1 0.01 72.52 50/250 MCG TWICE | 1 0.01 72.53 50/500 MG, 50 MG TWO TIMES A DAY | 1 0.01 72.54 500 CC | 1 0.01 72.55 500 MCG | 1 0.01 72.56 500 MG | 1 0.01 72.57 500 MG 10 TABLET TWICE DAILY FOR 5 DAYS | 1 0.01 72.58 500 MG 3 TABLETS PO | 1 0.01 72.59 500 MG DAILY | 1 0.01 72.60 500 MG, | 1 0.01 72.61 500 MG, 1X/DAY | 2 0.02 72.63 500 MG, 2/D | 1 0.01 72.64 500 MG, 2X/DAY | 4 0.04 72.68 500 MG, 3X/DAY | 4 0.04 72.72 500 MG, 4 TABLETS, BID | 1 0.01 72.73 500 MG, 4X/DAY | 1 0.01 72.74 500 MG, 4X/DAY (QID) | 1 0.01 72.75 500 MG, AS NEEDED | 1 0.01 72.76 500 MG, AS NEEDED AT EVERY 4 HRS | 1 0.01 72.77 500 MG, BID | 15 0.15 72.92 500 MG, Q4WK | 3 0.03 72.95 500 MG, QD | 39 0.39 73.34 500 MG, QD (DAILY) | 5 0.05 73.39 500 MG, QID | 2 0.02 73.41 500 MG, QMO | 3 0.03 73.44 500 MG, TID | 11 0.11 73.55 500 MG, UNK | 23 0.23 73.78 500 MG/DAY | 1 0.01 73.79 500 MG/M2, UNK | 2 0.02 73.81 500 ML DAILY DOSE | 1 0.01 73.82 500 ML, 1X/DAY | 2 0.02 73.84 500-50 MCG/ACT 1 INHALATION | 1 0.01 73.85 500/50 MCG | 2 0.02 73.87 500/50 MCG; 1 PUFF(S), UNK | 1 0.01 73.88 500/50 UG, UNK | 1 0.01 73.89 5000 IE | 1 0.01 73.90 5000 IU, QD | 1 0.01 73.91 5000 IU, UNK | 1 0.01 73.92 50000 UNT | 1 0.01 73.93 500MG 19SEP-11OCT11. | 1 0.01 73.94 500MG 3TABS BID FOR 7DAYS THEN OFF FO.. | 1 0.01 73.95 508 MG, TOTAL | 2 0.02 73.97 50MG Q2HR PRN | 1 0.01 73.98 52 U, UNKNOWN | 1 0.01 73.99 540MG DAILY | 1 0.01 74.00 55 MG, UNK | 1 0.01 74.01 5MG/500MG, 1-2 TABS BID | 1 0.01 74.02 5MG/500MG, 4X/DAY | 1 0.01 74.03 5MG/500MG, EVERY NIGHT AT BED TIME | 1 0.01 74.04 5MG/DIE | 1 0.01 74.05 5ML. 1/2 TEASPOON GIVEN,FREQUENCY UNK | 1 0.01 74.06 6 DF, QD | 1 0.01 74.07 6 G, 1D | 2 0.02 74.09 6 G, 2X/DAY | 1 0.01 74.10 6 IU, QD | 1 0.01 74.11 6 IU, TID | 1 0.01 74.12 6 MG, BID | 3 0.03 74.15 6 MG, ONCE DAILY (QD) | 1 0.01 74.16 6 MG, QD | 29 0.29 74.45 6 MG, QWK | 1 0.01 74.46 6 MG, TID | 1 0.01 74.47 6 MG, UNK | 3 0.03 74.50 6 MG/KG, Q2WK | 1 0.01 74.51 6 ML, QD | 1 0.01 74.52 6 TABLETS PER DAY | 1 0.01 74.53 6 U, UNKNOWN | 1 0.01 74.54 6 X 1/2 | 1 0.01 74.55 6.25 MG - 3.125 MG | 1 0.01 74.56 6.25 MG, 2X/DAY | 1 0.01 74.57 6.25 MG, UNK | 2 0.02 74.59 6.25-10 MG/5 ML 1-2 TSP EVERY 6 HRS, .. | 1 0.01 74.60 60 MG, 1X/DAY | 2 0.02 74.62 60 MG, 2X/DAY | 1 0.01 74.63 60 MG, BID | 1 0.01 74.64 60 MG, DAILY (1/D) | 1 0.01 74.65 60 MG, EACH MORNING | 1 0.01 74.66 60 MG, PRN | 1 0.01 74.67 60 MG, QD | 8 0.08 74.75 60 MG, UNK | 4 0.04 74.79 60 MG/M2, QD | 4 0.04 74.83 60 MG/M2, UNK | 4 0.04 74.87 60-600MG, TWO TIMES A DAY | 1 0.01 74.88 600 MG QD | 1 0.01 74.89 600 MG, 2X/DAY | 1 0.01 74.90 600 MG, AS NEEDED | 1 0.01 74.91 600 MG, AS NEEDED (PRN), RARELY | 1 0.01 74.92 600 MG, BID | 4 0.04 74.96 600 MG, INTERMITTENT | 1 0.01 74.97 600 MG, PRN | 1 0.01 74.98 600 MG, QD | 20 0.20 75.18 600 MG, QW | 6 0.06 75.24 600 MG, TID | 2 0.02 75.26 600 MG, UNK | 9 0.09 75.35 600 MG/M2, UNK | 1 0.01 75.36 600 UNK, UNK | 1 0.01 75.37 600/12.5 MG | 1 0.01 75.38 600/2.4, PEN QD | 1 0.01 75.39 60MG | 1 0.01 75.40 60MG DAILY | 1 0.01 75.41 62.5 MG, | 1 0.01 75.42 62.5 MG, BID | 2 0.02 75.44 625 MG, QD | 4 0.04 75.48 625 MG/ DAY | 1 0.01 75.49 644 MG, UNK | 1 0.01 75.50 65 MG, 3X/DAY (TID) | 1 0.01 75.51 65 MG, UNK | 1 0.01 75.52 650 MG, 1X/DAY | 1 0.01 75.53 650 MG, QD | 2 0.02 75.55 667 MG, UNK | 1 0.01 75.56 68 MG, UNK | 2 0.02 75.58 68.3 MCG/DAY | 1 0.01 75.59 7 DAYS | 1 0.01 75.60 7 INJECTION /WEEK | 1 0.01 75.61 7 MG | 1 0.01 75.62 7 MG, QD | 2 0.02 75.64 7.5 G, UNK | 1 0.01 75.65 7.5 MG, DAILY (5 MG IN THE MORNING AN.. | 1 0.01 75.66 7.5 MG, ONCE DAILY (QD) | 1 0.01 75.67 7.5 MG, QD | 7 0.07 75.74 7.5 MG, UNK | 3 0.03 75.77 7.5 MG./325 MG. EVERY 6 HOURS DAILY | 1 0.01 75.78 7.5 MG/500 MG EQUIVALENT | 2 0.02 75.80 7.5, DAILY | 1 0.01 75.81 7.5-500 MG | 1 0.01 75.82 7.5/325 MG, 1 TO 2 TIMES A DAY FOR AR.. | 1 0.01 75.83 7.5MG/500MG, 3X/DAY | 1 0.01 75.84 70 MG | 1 0.01 75.85 70 MG QW | 2 0.02 75.87 70 MG, QD | 1 0.01 75.88 70 MG, QW | 19 0.19 76.07 70 MG, UNK | 20 0.20 76.27 70 MG, UNKNOWN | 3 0.03 76.30 700 MG, WEEKLY | 1 0.01 76.31 70MG 1-0-1 RED TO 100 MG 1-0-0 50.. | 1 0.01 76.32 70MG/2800IU QW | 1 0.01 76.33 720 MG EVERY AM AND 480 MG EVERY PM | 1 0.01 76.34 740 MCG TWO TIMES A DAY | 2 0.02 76.36 75 ?G, QD | 2 0.02 76.38 75 ?G, UNK | 1 0.01 76.39 75 MG | 3 0.03 76.42 75 MG, 2X/DAY | 2 0.02 76.44 75 MG, 3X/DAY | 1 0.01 76.45 75 MG, BID | 1 0.01 76.46 75 MG, DAILY (1/D) | 1 0.01 76.47 75 MG, PRN (AS NEEDED) | 1 0.01 76.48 75 MG, QD | 12 0.12 76.60 75 MG, UNK | 9 0.09 76.69 75 MG/DAY | 1 0.01 76.70 75 MG/M2, QD | 1 0.01 76.71 75 MG/M2, UNK | 5 0.05 76.76 75-150 MG, DAILY | 1 0.01 76.77 750 MG (10MG/KG), EVERY 2 WEEKS | 1 0.01 76.78 750 MG, 1X/DAY:QD | 3 0.03 76.81 750 MG, BID | 3 0.03 76.84 750 MG, EVERY 10-12 HOURS IF NEEDED | 1 0.01 76.85 750 MG, PRN | 1 0.01 76.86 750 MG, Q4WK | 2 0.02 76.88 750 MG, QCYCLE | 2 0.02 76.90 750 MG, QD | 3 0.03 76.93 750 MG, QMO | 3 0.03 76.96 750 MG, UNK | 3 0.03 76.99 750 MG/M2, QMONTH | 1 0.01 77.00 790 MG, UNK | 2 0.02 77.02 8 DAY AND EVERY 14 DAY. | 7 0.07 77.09 8 DF, QD | 1 0.01 77.10 8 DOSES | 5 0.05 77.15 8 MG | 2 0.02 77.17 8 MG Q6-8 HRS | 1 0.01 77.18 8 MG, 1D | 4 0.04 77.22 8 MG, 1X/DAY | 2 0.02 77.24 8 MG, AS DIRECTED | 1 0.01 77.25 8 MG, BID | 2 0.02 77.27 8 MG, DAILY (2 (TWO) TABLET DAILY) | 1 0.01 77.28 8 MG, QD | 11 0.11 77.39 8 MG, QWK | 1 0.01 77.40 8 MG, TID | 1 0.01 77.41 8 MG, UNK | 7 0.07 77.48 8 U, TID | 1 0.01 77.49 8.5 MG, QD | 1 0.01 77.50 80 /4.5 MCG, UNKNOWN | 1 0.01 77.51 80 MCG, TWO TIMES A DAY | 1 0.01 77.52 80 MG | 1 0.01 77.53 80 MG 2 PUFFS BID | 1 0.01 77.54 80 MG X 8 TIMES IN 2 WEEKS | 1 0.01 77.55 80 MG, 1X/DAY | 2 0.02 77.57 80 MG, 3X/DAY | 1 0.01 77.58 80 MG, BID | 2 0.02 77.60 80 MG, DAILY | 1 0.01 77.61 80 MG, QD | 3 0.03 77.64 80 MG, UNK | 3 0.03 77.67 80 MG/M2, Q4WK | 1 0.01 77.68 80 MG/M2, QCYCLE | 1 0.01 77.69 80 MG/M2, UNK | 3 0.03 77.72 80/4.5 2 PUFFS TWICE DAILY | 1 0.01 77.73 80/4.5 MCG TWO PUFFS TWICE DAILY | 2 0.02 77.75 80/4.5 MCG, TWO PUFFS, TWICE DAILY | 1 0.01 77.76 80/4.5 MCG, UNKNOWN | 2 0.02 77.78 80/4.5 TWO PUFFS TWICE DAILY | 2 0.02 77.80 800 MG, 1D | 1 0.01 77.81 800 MG, QD | 4 0.04 77.85 800 MG, TID | 3 0.03 77.88 800 MG, UNK | 1 0.01 77.89 800 MG/M2, UNK | 6 0.06 77.95 800-160, BID | 1 0.01 77.96 800/160 MG | 1 0.01 77.97 8000 MG, QD | 1 0.01 77.98 80000 IU, QWK | 1 0.01 77.99 80000 IU, WEEKLY | 1 0.01 78.00 800MG 1-2 TABS DAILY | 1 0.01 78.01 81 MG | 2 0.02 78.03 81 MG, 1X/DAY | 1 0.01 78.04 81 MG, DAILY | 1 0.01 78.05 81 MG, DAILY (1/D) | 1 0.01 78.06 81 MG, OD | 1 0.01 78.07 81 MG, ONCE DAILY (QD) | 1 0.01 78.08 81 MG, QD | 1 0.01 78.09 81 MG, UNK | 1 0.01 78.10 81 MG, UNKNOWN | 1 0.01 78.11 81-325 MG DAILY TO EVERY OTHER DAY | 1 0.01 78.12 825 MG/M2, BID | 1 0.01 78.13 84 MG, 1X/DAY | 1 0.01 78.14 840 MG, UNK | 2 0.02 78.16 850 MG, BID | 2 0.02 78.18 850 MG, TID | 1 0.01 78.19 850 MG, UNK | 1 0.01 78.20 875-125 MG 1 TABLET TWICE DAILY FOR .. | 1 0.01 78.21 88 ?G, QD | 1 0.01 78.22 88 MG, QD | 1 0.01 78.23 88 UG, 1X/DAY | 1 0.01 78.24 8IU MORNING + 4IU EVENING | 2 0.02 78.26 9 MG, BID | 2 0.02 78.28 9 MG, QD | 1 0.01 78.29 9.5 MG, UNK | 1 0.01 78.30 90 ?G, INHALATION | 1 0.01 78.31 90 MCG, 2 PUFFS EVERY FOUR HOURS AS N.. | 1 0.01 78.32 90 MCG/INH. AREOSOL, 1 PUFF BID | 1 0.01 78.33 90 MCG/INH. AREOSOL, 2 PUFFS BID | 1 0.01 78.34 90 MG, DAILY | 1 0.01 78.35 90 MG, QD | 1 0.01 78.36 90 MG, UNK | 4 0.04 78.40 900 MG, Q2W | 6 0.06 78.46 900 MG, QD | 2 0.02 78.48 9000 IU, OTHER (WEEKLY) | 1 0.01 78.49 90MCG PRN | 1 0.01 78.50 9MAR10:UNK:0.6MG UNK:4AUG10:1.2IU RE.. | 1 0.01 78.51 AC | 2 0.02 78.53 AGAIN RECEIVED INTRAVENOUS 200MG/KG F.. | 1 0.01 78.54 AGAIN RECEIVED ORALLY FOR 2 WEEKS | 1 0.01 78.55 ALSO 6 G SIX TIMES DAILY DURING 3 DAYS | 1 0.01 78.56 ALSO INTRAMUSCULAR VIALS | 1 0.01 78.57 ALSO TAKEN 2/DAY (THE FOLLOWING DAY) | 1 0.01 78.58 ALSO TAKEN 20MG,30MG | 1 0.01 78.59 AMARYL TAB | 1 0.01 78.60 AMATESIA | 4 0.04 78.64 AND ALSO 10 MG TABLETS | 1 0.01 78.65 APPLY 1/2 STRIP DAILY | 1 0.01 78.66 APPROX SINCE 8 YEARS? DOSE:70 UNIT(S) | 1 0.01 78.67 APPROXIMATE TOTAL NUMBER OF INFUSIONS.. | 2 0.02 78.69 APPROXIMATELY 30 INFUSIONS RECEIVED. | 1 0.01 78.70 APROVEL FORTE TABS | 1 0.01 78.71 AS NEEDED | 7 0.07 78.78 AS PRESCRIBED | 1 0.01 78.79 AS REQUIRED | 6 0.06 78.85 ASPIRIN | 1 0.01 78.86 AT 24 WEEKS OF ENTECAVIR, THE DOSE WA.. | 1 0.01 78.87 AT 26, 29 AND 32 WEEKS GESTATION | 4 0.04 78.91 AT NIGHT | 7 0.07 78.98 AUC6 | 1 0.01 78.99 BID | 1 0.01 79.00 BID250 MG, UNK | 1 0.01 79.01 BUSCOPAN 20 MG/ML. 1DF=1 DOSE | 1 0.01 79.02 CAPS | 1 0.01 79.03 CAPSULE | 2 0.02 79.05 CEMIDON B6 300MG EMPTY STOMACH | 1 0.01 79.06 CODE NOT BROKEN | 1 0.01 79.07 CONCENTRATION 4MG/ML, ONCE EVERY 3 WE.. | 1 0.01 79.08 CONTINUOUS | 1 0.01 79.09 CORTANCYL 1 MG | 1 0.01 79.10 COURSE 1 | 1 0.01 79.11 CPS | 1 0.01 79.12 CUMMULATIVE DOSE UNTIL SEP-2011 WAS 2.. | 3 0.03 79.15 CUTTING THE 40 MG TABLET OF CRESTOR T.. | 2 0.02 79.17 DAILY | 43 0.43 79.60 DAILY DOSAGE UNKNOWN | 3 0.03 79.63 DAILY DOSE 10 MG | 1 0.01 79.64 DAILY DOSE 12.45 G | 1 0.01 79.65 DAILY DOSE 1500 G | 1 0.01 79.66 DAILY DOSE 3 G | 1 0.01 79.67 DAILY DOSE 50 MG | 1 0.01 79.68 DAILY DOSE: 10 MG | 2 0.02 79.70 DAILY DOSE: 3000 MG | 1 0.01 79.71 DAILY DOSE: 5 MG | 1 0.01 79.72 DAILY DOSE: 750 MG | 1 0.01 79.73 DAILY MOISTURIZER | 1 0.01 79.74 DATE OF INITIATION NOT REPORTED. INC.. | 1 0.01 79.75 DATE OF LAST DOSE PRIOR TO OTHER EPIS.. | 1 0.01 79.76 DATE OF LAST DOSE PRIOR TO SAE 07/JAN.. | 1 0.01 79.77 DATE OF LAST DOSE PRIOR TO SAE: 04/NO.. | 1 0.01 79.78 DATE OF LAST DOSE PRIOR TO SAE: 04/NO.. | 1 0.01 79.79 DATE OF LAST DOSE PRIOR TO SAE: 04/NO.. | 1 0.01 79.80 DATE OF LAST DOSE PRIOR TO SAE: 04/NO.. | 1 0.01 79.81 DATE OF LAST DOSE PRIOR TO SAE: 08/AU.. | 1 0.01 79.82 DATE OF LAST DOSE PRIOR TO SAE: 20/OC.. | 1 0.01 79.83 DATE OF LAST DOSE PRIOR TO SAE: 27/OC.. | 1 0.01 79.84 DATE OF LAST DOSE PRIOR TO SECOND EPI.. | 1 0.01 79.85 DATE OF LAST RITUXIMAB INFUSION: 16/D.. | 1 0.01 79.86 DATE OF MOST RECENT DOSE (100 MG) PRI.. | 1 0.01 79.87 DATE OF MOST RECENT DOSE (100MG) PRIO.. | 1 0.01 79.88 DATE OF MOST RECENT DOSE (1400 MG) PR.. | 1 0.01 79.89 DATE OF MOST RECENT DOSE (2 MG) PRIOR.. | 1 0.01 79.90 DATE OF MOST RECENT DOSE (2MG) PRIOR .. | 1 0.01 79.91 DATE OF MOST RECENT DOSE (91 MG) PRIO.. | 1 0.01 79.92 DATE OF MOST RECENT DOSE (94 MG) PRIO.. | 1 0.01 79.93 DATE OF MOST RECENT DOSE (VOLUME : 71.. | 1 0.01 79.94 DATE OF MOST RECENT DOSE OF BLINDED 1.. | 1 0.01 79.95 DATE OF MOST RECENT DOSE OF OPEN LABE.. | 1 0.01 79.96 DATE OF MOST RECENT DOSE PRIOR TO SAE.. | 1 0.01 79.97 DATE OF MOST RECENT DOSE PRIOR TO SAE.. | 1 0.01 79.98 DATE OF MOST RECENT DOSE PRIOR TO SAE.. | 1 0.01 79.99 DAY 1 | 7 0.07 80.06 DAY 1 DOSE | 1 0.01 80.07 DAY 1 EVERY OTHER MONTH. | 1 0.01 80.08 DAY 1 TO DAY 14, EVERY 21 DAYS. | 1 0.01 80.09 DAY 1, EVERY 21 DAYS | 2 0.02 80.11 DAY 1, EVERY 4 WEEKS | 1 0.01 80.12 DAY8 DOSE | 1 0.01 80.13 DAYS 8-10 | 1 0.01 80.14 DEC-04, 5 MG; DOSAGE INCREASED SLOWLY.. | 1 0.01 80.15 DF=3 TABS | 1 0.01 80.16 DF=TABS | 1 0.01 80.17 DIAZEPAM ^DAK^ TAB | 1 0.01 80.18 DISCONTINUED BEFORE CDT | 1 0.01 80.19 DIVIDED DOSES | 1 0.01 80.20 DOMINAL-FORTE | 1 0.01 80.21 DOSAGE CHANGE DUE TO DECREASE OF WEIGHT | 1 0.01 80.22 DOSAGE IS UNCERTAIN. | 9 0.09 80.31 DOSE 3MG | 1 0.01 80.32 DOSE AS USED: UNK | 2 0.02 80.34 DOSE CONCENTRATION: 0.93 MG/ML, VOLUM.. | 1 0.01 80.35 DOSE FORM: INJECTION FOR INFUSION (DA.. | 1 0.01 80.36 DOSE INCREASED TO 30MG/D | 1 0.01 80.37 DOSE INCREASED TO 7.5MG THEN REDUCED .. | 1 0.01 80.38 DOSE INCREASED:600 MG X 2 DAILY | 1 0.01 80.39 DOSE PER APPLICATION AND DAILY DOSE: .. | 1 0.01 80.40 DOSE REPORTED AS : 1 SACHET /DAY | 1 0.01 80.41 DOSE RPTD AS 125 MGR2 DG/ 80 MG | 1 0.01 80.42 DOSE: 10 UNITS | 1 0.01 80.43 DOSE: 1000 UNITS | 1 0.01 80.44 DOSE: 2 X 40 MG | 1 0.01 80.45 DOSE: 20 MG | 1 0.01 80.46 DOSE: 20000 | 1 0.01 80.47 DOSE: 255 MG | 1 0.01 80.48 DOSE:18 UNIT(S) | 1 0.01 80.49 DOSE:20 UNIT(S) | 2 0.02 80.51 DOSE:50MG/1000MG,2/D (1 IN THE MORNIN.. | 1 0.01 80.52 DOSE:78 UNIT(S) | 1 0.01 80.53 DOSE:80/12.5 DAILY. | 1 0.01 80.54 DRIP | 2 0.02 80.56 DRIP, 5,000-31,000 UNITS | 1 0.01 80.57 DROPS AND INTRAMUSCULAR VIALS | 1 0.01 80.58 DRUG NAME: KCL SUPPLETIE | 1 0.01 80.59 DURATION:5 OR 6 MONTHS. | 1 0.01 80.60 EFEXOR EX | 1 0.01 80.61 EVERY 6 [HOURS] PRN ( AS NEEDED | 1 0.01 80.62 EVERY DAY | 2 0.02 80.64 EVERY FOUR HOURS | 1 0.01 80.65 EVERY OTHER DAY | 1 0.01 80.66 EVERY OTHER WEEK | 1 0.01 80.67 EVERY THREE WEEKS | 1 0.01 80.68 F | 1 0.01 80.69 FILL DATE STATUS: 01-MAY-2011 (PART F.. | 1 0.01 80.70 FILL DATE STATUS: 02-APR-2011 (UNFILL.. | 1 0.01 80.71 FILL DATE STATUS: 06-JUL-2011 2 TABLETS | 1 0.01 80.72 FILL DATE STATUS: 07-JUL-2011 2 TO 3 .. | 1 0.01 80.73 FILL DATE STATUS: 08-AUG-2011 | 2 0.02 80.75 FILL DATE STATUS: 10-MAY-2011 | 1 0.01 80.76 FILL DATE STATUS: 16-AUG-2011 | 2 0.02 80.78 FILL DATE STATUS: 18-AUG-2011 (PART F.. | 1 0.01 80.79 FILL DATE STATUS: 19-JUN-2011 (PART F.. | 1 0.01 80.80 FILL DATE STATUS: 20-JUL-2011 PART FILL | 1 0.01 80.81 FILL DATE STATUS: 30-JUN-2011 (PART F.. | 1 0.01 80.82 FILM COATED | 1 0.01 80.83 FILM COATED TAB COZAAR COMP. 100 MG/.. | 1 0.01 80.84 FILM COATED TABLET | 2 0.02 80.86 FILM-COATED TABLET | 1 0.01 80.87 FLEXERIL, THREE TIMES A DAY | 2 0.02 80.89 FLUTICASONE PROPIONATE 250, SALMETERO.. | 1 0.01 80.90 FOR 1 WEEK | 1 0.01 80.91 FOR 4 WEEKS WITH A 2-WEEK REST PERIOD.. | 1 0.01 80.92 FOR 90 DAYS | 1 0.01 80.93 FOR ABOUT 10 DAYS | 1 0.01 80.94 FOR EVERY 12 HOURS FOR 3 WEEKS FOR E.. | 1 0.01 80.95 FOR MANY YEARS | 2 0.02 80.97 FOR MORE THAN 1 YEAR | 1 0.01 80.98 FOR SOME TIME | 1 0.01 80.99 FORM : TABLET | 1 0.01 81.00 FORM-TAB. | 1 0.01 81.01 FORM: CAPS | 1 0.01 81.02 FORM: CAPSULES. | 1 0.01 81.03 FORM: KARDEGIC 75 | 1 0.01 81.04 FORM: POWDER FOR ORAL SOLUTION SACHET | 2 0.02 81.06 FORM: PRE-FILLED SYRINGE, COMPLETED 4.. | 1 0.01 81.07 FORM: PREFILLED SYRINGE | 1 0.01 81.08 FORM: SCORED TABS | 2 0.02 81.10 FORM: SPIRONOLACTONE 50 | 1 0.01 81.11 FORM: TOCO 500 | 2 0.02 81.13 FORM:5MG | 1 0.01 81.14 FORMULATION: FILM-COATED AND SCORED T.. | 1 0.01 81.15 FORMULATION: TAB | 1 0.01 81.16 FORMULATION: TABS | 1 0.01 81.17 FREQUENCY 3 | 1 0.01 81.18 FREQUENCY- 1DF | 1 0.01 81.19 FREQUENCY: 1 | 1 0.01 81.20 FREQUENCY: 3X2 | 1 0.01 81.21 FREQUENCY: Q4S, DATE OF MOST RECENT D.. | 1 0.01 81.22 FREQUENCY: QS, DATE OF MOST RECENT DO.. | 1 0.01 81.23 FREQUENCY:DAILY | 1 0.01 81.24 FROM 11. TO 12. GESTATIONAL WEEK | 1 0.01 81.25 FROM 2MAY2006- 2 YEARS BACK: 10MG/DAY.. | 1 0.01 81.26 FULL DOSE | 1 0.01 81.27 FUROSEMIDE TABLET | 1 0.01 81.28 GASTRO-RESISTANT AND FILM-COATED TABLET | 2 0.02 81.30 GASTRO-RESISTANT CAPSULE THERAPY DURA.. | 1 0.01 81.31 GASTRO-RESISTANT TABLET | 1 0.01 81.32 GENERIC | 4 0.04 81.36 GENERIC 40 MG DAILY | 1 0.01 81.37 GENERIC CITALOPRAM TABLETS 40 MG DAILY | 2 0.02 81.39 GENERIC HCL XR, 150MG, TWO TIMES A DAY | 1 0.01 81.40 GENERIC QUETIAPINE, 25MG EVERY MORNING | 2 0.02 81.42 GENERIC QUETIAPINE, 300 MG AT NIGHT | 2 0.02 81.44 GENERIC, 100 MG, DAILY | 1 0.01 81.45 GENERIC, 200 MG AT NIGHT | 2 0.02 81.47 GENERIC, 75 MG DAILY | 1 0.01 81.48 GENERIC, 800 MG, TWO TIMES A DAY | 1 0.01 81.49 GIVE 1 TABLET VIA G- TUBE EVERY NIGHT.. | 1 0.01 81.50 GIVEN ON DAY ONE AS PER PROTOCOL, LAS.. | 2 0.02 81.52 GRANULES | 2 0.02 81.54 HARD CAPSULES,FREQ:IF NECESSARLY | 1 0.01 81.55 HIGH CALORIE SUPPLEMENT | 1 0.01 81.56 HS,2.5MG,PRN. | 1 0.01 81.57 HYDROCODONE BITARTRATE 7.5MG, PARACET.. | 1 0.01 81.58 IN 2 DIVIDED DOSES, COMPLETED 48 WEEK.. | 1 0.01 81.59 IN DRIP | 2 0.02 81.61 IN EMERGENCY SITUATIONS | 2 0.02 81.63 IN FIRST TRIMESTER | 1 0.01 81.64 INCREASED TO 12MG/DAY ON 20MAY11 | 2 0.02 81.66 INCREASED TO 20 MG ON 10-DEC-2003 AND.. | 1 0.01 81.67 INCREASED TO 5 MG 21OCT11 AND AGAIN R.. | 1 0.01 81.68 INCREASED TO 60 MG DAILY AT HS ON 23-.. | 1 0.01 81.69 INCREASED TO 60 MG DAILY ON 23-FEB-20.. | 1 0.01 81.70 INF:8,LAST INFUSION ON 24-MAY-2012 L.. | 1 0.01 81.71 INHALATION SOLUTION | 1 0.01 81.72 INJ. | 1 0.01 81.73 INJECTION | 2 0.02 81.75 INJECTION 80MG/0.8ML. | 1 0.01 81.76 INTEAD OF 6GM/DAY ,2MG/DAY INTRODUCED | 1 0.01 81.77 INTERRUPT FOR 2 DAYS | 1 0.01 81.78 INTERRUPTED ON 16MAY12 AND RESTAT ON .. | 1 0.01 81.79 INTERRUPTED ON 19JUN2012 | 1 0.01 81.80 INTERRUPTED ON 29-08-2012 AND RESTARTED | 1 0.01 81.81 IV FLUIDS | 1 0.01 81.82 LAST ADMINISTRATION PRIOR TO THE EVEN.. | 1 0.01 81.83 LAST ADMINISTRATION PRIOR TO THE EVEN.. | 1 0.01 81.84 LAST ADMINISTRATION PRIOR TO THE EVEN.. | 3 0.03 81.87 LAST DOSE 1370 MG PRIOR TO SAE ON 22/.. | 1 0.01 81.88 LAST DOSE : AUG 2011?(2 TABLETS, TWIC.. | 1 0.01 81.89 LAST DOSE ON /FEB/2012 | 1 0.01 81.90 LAST DOSE ON 23OCT11,2 VIALS OF 250MG.. | 1 0.01 81.91 LAST DOSE PRIOR TO EVENT 14/SEP/2012 | 4 0.04 81.95 LAST DOSE PRIOR TO EVENT 26/SEP/2012 | 1 0.01 81.96 LAST DOSE PRIOR TO SAE (BOTH OCCURREN.. | 4 0.04 82.00 LAST DOSE PRIOR TO SAE 16 AUG 2012 | 1 0.01 82.01 LAST DOSE PRIOR TO SAE 17 AUG 2010. | 1 0.01 82.02 LAST DOSE PRIOR TO SAE 20/APR/2008, R.. | 1 0.01 82.03 LAST DOSE PRIOR TO SAE ON 10 JUNE 2010. | 1 0.01 82.04 LAST DOSE PRIOR TO SAE ON 24 AUGUST 2.. | 1 0.01 82.05 LAST DOSE PRIOR TO SAE: 12/APR/2012, .. | 1 0.01 82.06 LAST DOSE RECEIVED ON 08/APR/2008 | 1 0.01 82.07 LAST DOSE RECEIVED ON 21/JUN/2012 | 1 0.01 82.08 LAST DOSE TAKEN 100 MG, LAST DOSE TAK.. | 1 0.01 82.09 LAST DOSE TAKEN 1357.5 MG, LAST DOSE .. | 1 0.01 82.10 LAST DOSE TAKEN 2 MG, LAST DOSE TAKEN.. | 1 0.01 82.11 LAST DOSE TAKEN 500 ML, LAST DOSE CON.. | 1 0.01 82.12 LAST DOSE TAKEN 90 MG, LAST DOSE TAKE.. | 1 0.01 82.13 LAST DOSE WAS GIVEN ON 19JUL2012,CYCL.. | 1 0.01 82.14 LAST DOSE-10JAN10 | 1 0.01 82.15 LAST DOSE: 19 DEC2011 | 1 0.01 82.16 LAST RITUXIMAB INFUSION: 25/FEB/2014 | 1 0.01 82.17 LASTEST INFUSION 01/DEC/2015 | 1 0.01 82.18 LATEST INFUSION WAS PERFORMED ON 25-O.. | 1 0.01 82.19 LEVEMIR SOULTION FOR INJECTION SUBCUT.. | 1 0.01 82.20 LIFELONG | 1 0.01 82.21 LIQUID | 1 0.01 82.22 LOADING DOSE | 2 0.02 82.24 LOADING DOSE FOLLOWED BY MAINTAINENCE.. | 1 0.01 82.25 MAINTAINANCE THERAPY | 1 0.01 82.26 MAINTENANCE DOSE | 1 0.01 82.27 MAINTENANCE FOR 2 YEARS | 1 0.01 82.28 METFORMINA CLORIDRATO TABLET | 1 0.01 82.29 METROTRESSATO SALE SODICO | 1 0.01 82.30 MIXTURE.100000U/ML | 1 0.01 82.31 MONDAY-SATURDAY | 1 0.01 82.32 MORNING | 1 0.01 82.33 MOST RECENT DOSE PRIOR TO BOTH THE OC.. | 1 0.01 82.34 MOST RECENT DOSE PRIOR TO SERIOUS ADV.. | 1 0.01 82.35 MOST RECENT DOSE PROIR TO SAE JUL/2014 | 1 0.01 82.36 MOST RECENT DOSE(CONCENTRATION: 2.74 .. | 1 0.01 82.37 MOTHER DOSE (400 MG, 600 MG, 800 MG D.. | 1 0.01 82.38 MOUTH WASH | 2 0.02 82.40 MOUTHWASH.AFTER EACH MEAL AND AT BED .. | 1 0.01 82.41 MOUTHWASH.BEFORE EACH MEAL | 1 0.01 82.42 NO CYCLE DURING PREGNANCY:1 NO CYCLE.. | 2 0.02 82.44 NO OF COURSE: 1 | 2 0.02 82.46 NO OF COURSES:4 | 1 0.01 82.47 NO OF INF:3 | 1 0.01 82.48 NORVASC 10MG TABS | 1 0.01 82.49 NOVATREX 2.5MG 1 D.F=8 TABLETS/WEEK | 1 0.01 82.50 OCCASIONAL CETIRIZINE | 5 0.05 82.55 OFF AND ON USE | 2 0.02 82.57 ON 200MG AND ONE 300MG PILL AT BEDTIME | 2 0.02 82.59 ON CHEST WALL | 1 0.01 82.60 ON DAY 1; LAST DOSE PRIOR TO SAE:20 A.. | 2 0.02 82.62 ON DAYS 1-3 | 3 0.03 82.65 ONCE | 22 0.22 82.87 ONCE EVERY 4 WEEKS | 1 0.01 82.88 ONCE EVERY THREE WEEKS | 1 0.01 82.89 ONCE IN 4-6 HOURS | 1 0.01 82.90 ONCE IN 4-6 HOURS. | 1 0.01 82.91 ONCE IN FOUR WEEKS | 1 0.01 82.92 ONE AND ONE HALF PILLS OF IBUPROFEN E.. | 1 0.01 82.93 ONE PUFF TWICE DAILY | 1 0.01 82.94 ONE RIBBON TO BOTH EYES | 1 0.01 82.95 ONE SINGLE DOSE, STOP DATE: 2010 | 1 0.01 82.96 ONE TABLET 4 TIMES A DAY. | 1 0.01 82.97 ONE TABLET FOUR TIMES A DAY | 1 0.01 82.98 ONE TABLET ORALLY TWICE DAILY | 2 0.02 83.00 ONE TO TWO 50MG TABLETS, 4X/DAY | 1 0.01 83.01 ONE TO TWO 5MG TABLETS, 1X/DAY | 1 0.01 83.02 ONE TO TWO CAPSULES WERE USED THREE T.. | 1 0.01 83.03 ONGOING AT CONCEPTION | 1 0.01 83.04 OPTHALAMIC (2 DROPS) | 1 0.01 83.05 OTSUKA, | 1 0.01 83.06 OVER 3 HOURS ON DAY 1 | 2 0.02 83.08 OVER 30 MIN FOR 15 WKS | 1 0.01 83.09 OVER 30 MINUTES FOR EVERY WEEK ON DAY.. | 1 0.01 83.10 OVER 30 MINUTES ON DAY 1 AND 8 | 1 0.01 83.11 OVER 30 MINUTES ON DAYA 1 AND 8 | 1 0.01 83.12 OVER 30-90 MINUTES ON DAYS 1,8, AND 15 | 1 0.01 83.13 OVER 30-90 MINUTES ON DAYS 1,8,15. DO.. | 1 0.01 83.14 OVER 40MG | 1 0.01 83.15 OVER 90 MIN WK 1 | 1 0.01 83.16 OVER 90 MINUTES ON DAY 1 OF CYCLE 1 | 1 0.01 83.17 PAST 6 MONTHS | 3 0.03 83.20 PATIENT REFILLED RX APPROXIMATELY 2 T.. | 1 0.01 83.21 POWDER FOR CONCENTRATE FOR SOLN FOR I.. | 1 0.01 83.22 PRE-STUDY. | 1 0.01 83.23 PRN | 2 0.02 83.25 PROLONGED-RELEASE TABLET | 1 0.01 83.26 QUESTRAN POWDER 4 G HALF A SACHET A D.. | 1 0.01 83.27 RALTEGRAVIR 400 MG TABS | 1 0.01 83.28 RECEIVED ON 21/DEC/2011, 11/JAN/2012 | 2 0.02 83.30 RECEIVED ON 30/NOV/2011 | 1 0.01 83.31 RECEIVED ON 30/NOV/2011, 11/JAN/2012 | 2 0.02 83.33 RECEIVED SUBSEQUENT DOSES ON 07/FEB/2.. | 1 0.01 83.34 REINTRODUCED AFTER THE MISCARRIAGE | 1 0.01 83.35 REPORTED AS 2DD. | 1 0.01 83.36 REPORTED AS 3DD. | 1 0.01 83.37 ROUTE: LOCAL | 1 0.01 83.38 ROUTE:IV | 1 0.01 83.39 SACHETS | 1 0.01 83.40 SCORED FILM TABS 2MG | 1 0.01 83.41 SCORED TABS. INTERRUPTED ON 20JUN12, .. | 1 0.01 83.42 SECOND DOSE | 1 0.01 83.43 SEROQUEL 100 MG AND 400 MG | 2 0.02 83.45 SINCE 5 YEARS | 1 0.01 83.46 SINCE THE BEGINNING OF 2011 | 1 0.01 83.47 SINGLE DOSE | 10 0.10 83.57 SINGLE USE VIAL, DOSAGE FORM WAS POWD.. | 1 0.01 83.58 SIX PER DAY | 1 0.01 83.59 SLIDING SCALE | 1 0.01 83.60 SR GENERIC, 150MG, | 1 0.01 83.61 STARTED 40+YEARS | 1 0.01 83.62 STARTED ABOUT TWO MONTHS AGO,15MG | 1 0.01 83.63 STARTED BETWEEN THE 19TH AND THE 26TH.. | 3 0.03 83.66 STOPPED AFTER SECOND INFUSION DUE TO .. | 1 0.01 83.67 STRENGTH REPORTED AS 40 MG AND 20 MG. | 1 0.01 83.68 STRENGTH: TABLET | 1 0.01 83.69 STRENGTH:20MG/ML | 1 0.01 83.70 STRENGTH:3MG/KG VS 10MG/KG,COURSE:2 .. | 1 0.01 83.71 STYRKE: 0,5 MG | 1 0.01 83.72 STYRKE: 100 MG. DOSIS: 100 MG VED BEH.. | 1 0.01 83.73 STYRKE: 15 MG | 1 0.01 83.74 STYRKE: 5 MG | 1 0.01 83.75 SUB-TENON;1DF-40MG FOR RIGHT AND 40MG.. | 1 0.01 83.76 SUBSEQUENT DOSE FROM 27/DEC/2012 TO 3.. | 1 0.01 83.77 SUBSEQUENT DOSES ON 18/OCT/2012, 08/N.. | 1 0.01 83.78 SUBSEQUENT DOSES ON 27/SEP/2012 TO 01.. | 1 0.01 83.79 SUNSEQUENT DOSE ON 27/SEP/2012, 18/OC.. | 1 0.01 83.80 TAB,1DF: 200MG/245MG | 1 0.01 83.81 TABLET | 12 0.12 83.93 TABLET,MORNING | 1 0.01 83.94 TABLETS | 4 0.04 83.98 TABS | 28 0.28 84.26 TABS, 100MG DAILY | 1 0.01 84.27 TAKE UPTO 1.5 MG DAILY | 1 0.01 84.28 TAKE 1 AT BEDTIME | 3 0.03 84.31 TAKE 1 CAPSULE 30-60 MIN PRIOR TO MEALS | 1 0.01 84.32 TAKE 1 CAPSULE AT BEDTIME | 1 0.01 84.33 TAKE 1 EVERY 8 HOURS AS NEEDED | 1 0.01 84.34 TAKE 1 OR 2 TABLETS EVERY 4-6 HR AS N.. | 1 0.01 84.35 TAKE 1 TABLET AT BEDTIME | 1 0.01 84.36 TAKE 1 TABLET EVERY 6 HRS AS NEEDED | 1 0.01 84.37 TAKE 1/2 TO 1 TAB EVERY 4-6 HR AS NEE.. | 1 0.01 84.38 TAKE ONE AS NEEDED | 6 0.06 84.44 TAKE ONE EVERY 12 HRS | 1 0.01 84.45 TAKE ONE EVERY 12 HRS AS NEEDED | 1 0.01 84.46 TAKE ONE TABLET | 1 0.01 84.47 TAKEN IT ONE HOUR PRIOR TO A MEAL | 2 0.02 84.49 TAKEN ON DAYS 1-14 EVERY 21 DAYS | 1 0.01 84.50 TAKING HALF THE DOSE | 2 0.02 84.52 THE DOSE WAS ADJUSTED TO KEEP ACTIVAT.. | 1 0.01 84.53 THEN 240MG/M2/HR OVER 23HRS | 1 0.01 84.54 THERAPY ON DAY 1 | 1 0.01 84.55 THERAPY ONGOING | 1 0.01 84.56 THERAPY STARTED APPROXIMATELY 1 YR BA.. | 1 0.01 84.57 THREE TIMES A DAY | 2 0.02 84.59 TID,PRN. | 1 0.01 84.60 TITRATED UP TO 1 MG QID | 1 0.01 84.61 TOTAL DAILY DOSE : 3000 MG | 1 0.01 84.62 TOTAL OF 13 DOSES RECEIVED | 2 0.02 84.64 TOTALIP TABS | 1 0.01 84.65 TWICE DAILY | 3 0.03 84.68 TWICE YEARLY | 1 0.01 84.69 TWO PUFFS TWICE DAILY | 1 0.01 84.70 TWO SPRAYS EACH NOSTRIL TWICE PER DAY | 1 0.01 84.71 TWO TABLETS EVERY EVENING AT DINNER | 1 0.01 84.72 TWO TIMES A DAY | 8 0.08 84.80 TWO WEEKS TREATMENT FOLLOWED BY ONE W.. | 1 0.01 84.81 UNIT DOSE: 25 MG/5ML | 1 0.01 84.82 UNIT DOSE: 250MG/5ML | 1 0.01 84.83 UNIT: 240MG/5ML | 1 0.01 84.84 UNK | 1,280 12.80 97.64 UNK (QUARTERLY) | 1 0.01 97.65 UNK DF, UNK | 6 0.06 97.71 UNK MG, UNK | 3 0.03 97.74 UNK OT, PRN | 2 0.02 97.76 UNK QD | 1 0.01 97.77 UNK UKN, UNK | 19 0.19 97.96 UNK UKN, UNK (PRN) | 1 0.01 97.97 UNK UNK, 2 TIMES/WK | 2 0.02 97.99 UNK UNK, 2X/DAY | 1 0.01 98.00 UNK UNK, 3X/DAY | 1 0.01 98.01 UNK UNK, BID | 4 0.04 98.05 UNK UNK, EVERY 2 TO 4 WEEKS | 1 0.01 98.06 UNK UNK, PRN | 16 0.16 98.22 UNK UNK, Q2WK | 3 0.03 98.25 UNK UNK, QCYCLE | 6 0.06 98.31 UNK UNK, QD | 13 0.13 98.44 UNK UNK, QMO | 2 0.02 98.46 UNK UNK, QWK | 2 0.02 98.48 UNK UNK, TID | 1 0.01 98.49 UNK UNK, U | 1 0.01 98.50 UNK UNK, UNK | 10 0.10 98.60 UNK UNK, UNKNOWN | 5 0.05 98.65 UNK UNK, UNKNOWN FREQ. | 32 0.32 98.97 UNK, (2 MG--1-2 CAPS Q 6 PRN) | 1 0.01 98.98 UNK, 10/12.5 MG DAILY | 1 0.01 98.99 UNK, 1X/DAY | 2 0.02 99.01 UNK, 2000 IU DAILY | 1 0.01 99.02 UNK, 3X/DAY:TID | 1 0.01 99.03 UNK, AS NEEDED | 2 0.02 99.05 UNK, AS NEEDED ((TWO) PUFF, PUFF EVER.. | 1 0.01 99.06 UNK, AS NEEDED (PRN) | 1 0.01 99.07 UNK, AS NEEDED, (PRN) | 2 0.02 99.09 UNK, AS PRESCRIBED AND DIRECTED | 1 0.01 99.10 UNK, CONCURRENT 75 MG/M2/D, DURING RT | 1 0.01 99.11 UNK, DAILY | 1 0.01 99.12 UNK, EACH EVENING | 1 0.01 99.13 UNK, EVERY 4 HRS (2 (TWO) PUFF, PUFF .. | 1 0.01 99.14 UNK, FORMULATION: POR (UNSPECIFIED) | 1 0.01 99.15 UNK, HARD | 1 0.01 99.16 UNK, ONCE A MONTH | 1 0.01 99.17 UNK, PRN | 6 0.06 99.23 UNK, Q2WK | 1 0.01 99.24 UNK, QCYCLE | 1 0.01 99.25 UNK, QD | 6 0.06 99.31 UNK, QMO | 1 0.01 99.32 UNK, QWK | 2 0.02 99.34 UNK, SINGLE | 1 0.01 99.35 UNK, U | 3 0.03 99.38 UNK, UNK | 1 0.01 99.39 UNK, UNK, UNKNOWN FREQ. | 1 0.01 99.40 UNK, UNKNOWN | 11 0.11 99.51 UNK, UNKNOWN FREQ. | 13 0.13 99.64 UNK,UNK, UNKNOWN FREQ. | 1 0.01 99.65 UNK-14JUN2012 | 1 0.01 99.66 UNK/ ON THE FACE AND NECK | 1 0.01 99.67 UNK/APPLIED TO SORE AREAS OF THE TOES.. | 1 0.01 99.68 UNK; TAKEN FOR TEN YEARS | 1 0.01 99.69 UNKNOWN | 1 0.01 99.70 UNKNOWN DOSE | 1 0.01 99.71 UNKNOWN DOSE THREE TABLETS, 3X/DAY | 1 0.01 99.72 UNKNOWN DOSE TWO TABLETS, 3X/DAY | 1 0.01 99.73 UNKNOWN DOSE, DAILY | 1 0.01 99.74 UNKNOWN DOSE, TWO TIMES A DAY | 1 0.01 99.75 UNKNOWN DOSE, WEEKLY | 1 0.01 99.76 UNTIL JUL12 | 1 0.01 99.77 UPDATE (03MAY2012)- USED FOR PREVENTI.. | 1 0.01 99.78 VAGINA CAPSULE ADMINISTERED ON 21,25 .. | 1 0.01 99.79 VALPRESSION CAPSULES | 1 0.01 99.80 VIAL | 1 0.01 99.81 VIALS | 1 0.01 99.82 WEDNESDAYS | 1 0.01 99.83 WEEKS 0-2-4 | 1 0.01 99.84 WEEKS(2,4,6,8,10,12) | 1 0.01 99.85 WHEN NECESSARY | 2 0.02 99.87 WITH A 12HOUR MESNA TAIL | 1 0.01 99.88 YEARLY | 1 0.01 99.89 [AMLODIPINE 5MG]/[ATORVASTATIN 10 MG].. | 1 0.01 99.90 ^DOSE: 0.2; UNIT: 1^ | 1 0.01 99.91 ^DOSE: 1000; UNIT: 1; ROUTE: ORAL^ | 1 0.01 99.92 ^DOSE: 10; ROUTE: LOCAL^ | 1 0.01 99.93 ^DOSE: 20; UNIT: 3/4^ | 1 0.01 99.94 ^DOSE: 20^ | 1 0.01 99.95 ^DOSE: 3.75^ | 1 0.01 99.96 ^DOSE: 5^ | 1 0.01 99.97 ^DOSE: 80; UNIT: 1/2^ | 1 0.01 99.98 ^DOSE: 80; UNIT: 1^ | 1 0.01 99.99 } 20 MG | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 6 Apr 2017